ORGANIC ELECTROLUMINESCENT DEVICE

20170358753 · 2017-12-14

Assignee

Inventors

Cpc classification

International classification

Abstract

The present invention provides an organic electroluminescent device having at least an anode, a hole transport layer, a luminous layer, an electron transport layer, and a cathode in this order, wherein the hole transport layer contains an arylamine compound having a specific structure, and the luminous layer contains an indenoindole derivative or a carbazole derivative having a specific structure. The organic EL device of the present invention is an organic EL device improved in luminous efficiency, driving voltage and durability.

Claims

1. An organic electroluminescent device having at least an anode, a hole transport layer, a luminous layer, an electron transport layer, and a cathode in this order, wherein the hole transport layer contains an arylamine compound represented by the following general formula (1), and the luminous layer contains an indenoindole derivative represented by the following general formula (2) or a carbazole derivative represented by the following general formula (3): ##STR00077## where Ar.sup.1 to Ar.sup.4 each represent an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, ##STR00078## where A.sup.1 represents a divalent group of an aromatic hydrocarbon, a divalent group of an aromatic heterocycle, a divalent group of a condensed polycyclic aromatic ring, or a single bond, Ar.sup.5 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, R.sup.1 to R.sup.8 each represent a hydrogen atom; a deuterium atom; a fluorine atom; a chlorine atom; a cyano group; a nitro group; an alkyl group having 1 to 6 carbon atoms; a cycloalkyl group having 5 to 10 carbon atoms; an alkenyl group having 2 to 6 carbon atoms; an alkyloxy group having 1 to 6 carbon atoms; a cycloalkyloxy group having 5 to 10 carbon atoms; an aromatic hydrocarbon group; an aromatic heterocyclic group; a condensed polycyclic aromatic group; an aryloxyl group; or a di-substituted amino group having an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group as a substituent, R.sup.1 to R.sup.4 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring, R.sup.5 to R.sup.8 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring, part of R.sup.1 to R.sup.4 may be detached, and remaining group of R.sup.1 to R.sup.4 may be bonded to a vacancy, which has been produced by detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring, part of R.sup.5 to R.sup.8 may be detached, and remaining group of R.sup.5 to R.sup.8 may be bonded to a vacancy, which has been produced by detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring, and R.sup.9 and R.sup.10 each represent an alkyl group having 1 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and R.sup.9 and R.sup.10 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring, ##STR00079## where A.sup.2 represents a divalent group of an aromatic hydrocarbon, a divalent group of an aromatic heterocycle, a divalent group of a condensed polycyclic aromatic ring, or a single bond, Ar.sup.6 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, R.sup.11 to R.sup.18 each represent a hydrogen atom; a deuterium atom; a fluorine atom; a chlorine atom; a cyano group; a nitro group; an alkyl group having 1 to 6 carbon atoms; a cycloalkyl group having 5 to 10 carbon atoms; an alkenyl group having 2 to 6 carbon atoms; an alkyloxy group having 1 to 6 carbon atoms; a cycloalkyloxy group having 5 to 10 carbon atoms; an aromatic hydrocarbon group; an aromatic heterocyclic group; a condensed polycyclic aromatic group; an aryloxyl group; or a di-substituted amino group having an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group as a substituent, R.sup.11 to R.sup.14 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring, R.sup.15 to R.sup.18 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring, part of R.sup.11 to R.sup.14 may be detached, and remaining group of R.sup.11 to R.sup.14 may be bonded to a vacancy, which has been produced by detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring, and part of R.sup.15 to R.sup.18 may be detached, and remaining group of R.sup.15 to R.sup.18 may be bonded to a vacancy, which has been produced by detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring.

2. The organic electroluminescent device according to claim 1, wherein the electron transport layer contains a pyrimidine derivative represented by the following general formula (4): ##STR00080## where Ar.sup.7 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, Ar.sup.8 and Ar.sup.9 each represent a hydrogen atom, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and Ar.sup.8 and Ar.sup.9 are each not a hydrogen atom simultaneously, and B represents a monovalent group represented by the following structural formula (5): ##STR00081## where Ar.sup.10 represents an aromatic heterocyclic group, R.sup.19 to R.sup.22 each represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a cyano group, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and R.sup.19 to R.sup.22 and Ar.sup.10 may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

3. The organic electroluminescent device according to claim 2, wherein the pyrimidine derivative is represented by the following general formula (4a): ##STR00082## where Ar.sup.7 to Ar.sup.9 and B are as defined in the general formula (4).

4. The organic electroluminescent device according to claim 2, wherein the pyrimidine derivative is represented by the following general formula (4b): ##STR00083## where Ar.sup.7 to Ar.sup.9 and B are as defined in the general formula (4).

5. The organic electroluminescent device according to claim 2, wherein in the general formula (4), B is a monovalent group represented by the following structural formula (5a): ##STR00084## where Ar.sup.10 and R.sup.19 to R.sup.22 are as defined in the structural formula (5).

6. The organic electroluminescent device according to claim 1, wherein the hole transport layer has a two-layer structure composed of a first hole transport layer and a second hole transport layer, and the second hole transport layer is located on a side of the luminous layer and contains the arylamine compound represented by the general formula (1).

7. The organic electroluminescent device according to claim 1, wherein the luminous layer contains a red luminous material.

8. The organic electroluminescent device according to claim 1, wherein the luminous layer contains a phosphorescent luminous material.

9. The organic electroluminescent device according to claim 8, wherein the phosphorescent luminous material is a metal complex containing iridium or platinum.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0065] FIG. 1 is a view showing the configurations of organic EL devices of Examples 1 to 12 and Comparative Examples 1 to 3.

[0066] FIG. 2 is a view showing the structural formulas of Compounds (1-1) to (1-7) which are arylamine compounds of the general formula (1).

[0067] FIG. 3 is a view showing the structural formulas of Compounds (1-8) to (1-14) which are arylamine compounds of the general formula (1).

[0068] FIG. 4 is a view showing the structural formulas of Compounds (1-15) to (1-21) which are arylamine compounds of the general formula (1).

[0069] FIG. 5 is a view showing the structural formulas of Compounds (1-22) to (1-27) which are arylamine compounds of the general formula (1).

[0070] FIG. 6 is a view showing the structural formulas of Compounds (1-28) to (1-33) which are arylamine compounds of the general formula (1).

[0071] FIG. 7 is a view showing the structural formulas of Compounds (1-34) to (1-39) which are arylamine compounds of the general formula (1).

[0072] FIG. 8 is a view showing the structural formulas of Compounds (1-40) to (1-45) which are arylamine compounds of the general formula (1).

[0073] FIG. 9 is a view showing the structural formulas of Compounds (1-46) to (1-50) which are arylamine compounds of the general formula (1).

[0074] FIG. 10 is a view showing the structural formulas of Compounds (1-51) to (1-55) which are arylamine compounds of the general formula (1).

[0075] FIG. 11 is a view showing the structural formulas of Compounds (1-56) to (1-59) which are arylamine compounds of the general formula (1).

[0076] FIG. 12 is a view showing the structural formulas of Compounds (1-60) to (1-64) which are arylamine compounds of the general formula (1).

[0077] FIG. 13 is a view showing the structural formulas of Compounds (1-65) to (1-70) which are arylamine compounds of the general formula (1).

[0078] FIG. 14 is a view showing the structural formulas of Compounds (1-71) to (1-76) which are arylamine compounds of the general formula (1).

[0079] FIG. 15 is a view showing the structural formulas of Compounds (1-77) to (1-81) which are arylamine compounds of the general formula (1).

[0080] FIG. 16 is a view showing the structural formulas of Compounds (1-82) to (1-87) which are arylamine compounds of the general formula (1).

[0081] FIG. 17 is a view showing the structural formulas of Compounds (1-88) to (1-93) which are arylamine compounds of the general formula (1).

[0082] FIG. 18 is a view showing the structural formulas of Compounds (1-94) to (1-99) which are arylamine compounds of the general formula (1).

[0083] FIG. 19 is a view showing the structural formulas of Compounds (1-100) to (1-105) which are arylamine compounds of the general formula (1).

[0084] FIG. 20 is a view showing the structural formulas of Compounds (2-1) to (2-5) which are indenoindole derivatives of the general formula (2).

[0085] FIG. 21 is a view showing the structural formulas of Compounds (2-6) to (2-10) which are indenoindole derivatives of the general formula (2).

[0086] FIG. 22 is a view showing the structural formulas of Compounds (2-11) to (2-15) which are indenoindole derivatives of the general formula (2).

[0087] FIG. 23 is a view showing the structural formulas of Compounds (3-1) to (3-6) which are carbazole derivatives of the general formula (3).

[0088] FIG. 24 is a view showing the structural formulas of Compounds (3-7) to (3-12) which are carbazole derivatives of the general formula (3).

[0089] FIG. 25 is a view showing the structural formulas of Compounds (3-13) to (3-18) which are carbazole derivatives of the general formula (3).

[0090] FIG. 26 is a view showing the structural formulas of Compounds (3-19) to (3-23) which are carbazole derivatives of the general formula (3).

[0091] FIG. 27 is a view showing the structural formulas of Compounds (4-1) to (4-6) which are pyrimidine derivatives of the general formula (4).

[0092] FIG. 28 is a view showing the structural formulas of Compounds (4-7) to (4-11) which are pyrimidine derivatives of the general formula (4).

[0093] FIG. 29 is a view showing the structural formulas of Compounds (4-12) to (4-16) which are pyrimidine derivatives of the general formula (4).

[0094] FIG. 30 is a view showing the structural formulas of Compounds (4-17) to (4-21) which are pyrimidine derivatives of the general formula (4).

[0095] FIG. 31 is a view showing the structural formulas of Compounds (4-22) to (4-26) which are pyrimidine derivatives of the general formula (4).

[0096] FIG. 32 is a view showing the structural formulas of Compounds (4-27) to (4-31) which are pyrimidine derivatives of the general formula (4).

[0097] FIG. 33 is a view showing the structural formulas of Compounds (4-32) to (4-36) which are pyrimidine derivatives of the general formula (4).

[0098] FIG. 34 is a view showing the structural formulas of Compounds (4-37) to (4-41) which are pyrimidine derivatives of the general formula (4).

[0099] FIG. 35 is a view showing the structural formulas of Compounds (4-42) to (4-46) which are pyrimidine derivatives of the general formula (4).

[0100] FIG. 36 is a view showing the structural formulas of Compounds (4-47) to (4-51) which are pyrimidine derivatives of the general formula (4).

[0101] FIG. 37 is a view showing the structural formulas of Compounds (4-52) to (4-56) which are pyrimidine derivatives of the general formula (4).

[0102] FIG. 38 is a view showing the structural formulas of Compounds (4-57) to (4-61) which are pyrimidine derivatives of the general formula (4).

[0103] FIG. 39 is a view showing the structural formulas of Compounds (4-62) to (4-66) which are pyrimidine derivatives of the general formula (4).

[0104] FIG. 40 is a view showing the structural formulas of Compounds (4-67) to (4-71) which are pyrimidine derivatives of the general formula (4).

[0105] FIG. 41 is a view showing the structural formulas of Compounds (4-72) to (4-76) which are pyrimidine derivatives of the general formula (4).

[0106] FIG. 42 is a view showing the structural formulas of Compounds (4-77) to (4-80) which are pyrimidine derivatives of the general formula (4).

[0107] FIG. 43 is a view showing the structural formulas of Compounds (4-81) to (4-84) which are pyrimidine derivatives of the general formula (4).

[0108] FIG. 44 is a view showing the structural formulas of Compounds (4-85) to (4-88) which are pyrimidine derivatives of the general formula (4).

[0109] FIG. 45 is a view showing the structural formulas of Compounds (4-89) to (4-92) which are pyrimidine derivatives of the general formula (4).

[0110] FIG. 46 is a view showing the structural formulas of Compounds (4-93) to (4-96) which are pyrimidine derivatives of the general formula (4).

[0111] FIG. 47 is a view showing the structural formulas of Compounds (4-97) to (4-100) which are pyrimidine derivatives of the general formula (4).

[0112] FIG. 48 is a view showing the structural formulas of Compounds (4-101) to (4-104) which are pyrimidine derivatives of the general formula (4).

[0113] FIG. 49 is a view showing the structural formulas of Compounds (4-105) to (4-108) which are pyrimidine derivatives of the general formula (4).

[0114] FIG. 50 is a view showing the structural formulas of Compounds (4-109) to (4-112) which are pyrimidine derivatives of the general formula (4).

[0115] FIG. 51 is a view showing the structural formulas of Compounds (4-113) to (4-116) which are pyrimidine derivatives of the general formula (4).

[0116] FIG. 52 is a view showing the structural formulas of Compounds (4-117) to (4-120) which are pyrimidine derivatives of the general formula (4).

[0117] FIG. 53 is a view showing the structural formulas of Compounds (4-121) to (4-124) which are pyrimidine derivatives of the general formula (4).

[0118] FIG. 54 is a view showing the structural formulas of Compounds (4-125) to (4-126) which are pyrimidine derivatives of the general formula (4).

[0119] FIG. 55 is a view showing the structural formulas of Compounds (6-1) to (6-5) which are triarylamine compounds of the general formula (6).

[0120] FIG. 56 is a view showing the structural formulas of Compounds (6-6) to (6-10) which are triarylamine compounds of the general formula (6).

[0121] FIG. 57 is a view showing the structural formulas of Compounds (6-11) to (6-15) which are triarylamine compounds of the general formula (6).

[0122] FIG. 58 is a view showing the structural formulas of Compounds (6-16) to (6-20) which are triarylamine compounds of the general formula (6).

[0123] FIG. 59 is a view showing the structural formulas of Compounds (6-21) to (6-23) which are triarylamine compounds of the general formula (6).

[0124] FIG. 60 is a view showing the structural formulas of Compounds (6′-1) and (6′-2), other than triarylamine compounds of the general formula (6), among triarylamine compounds having two triarylamine structures.

[0125] FIG. 61 is a view showing the structural formulas of Compounds (7-1) to (7-5) which are triarylamine compounds of the general formula (7).

[0126] FIG. 62 is a view showing the structural formulas of Compounds (7-6) to (7-9) which are triarylamine compounds of the general formula (7).

[0127] FIG. 63 is a view showing the structural formulas of Compounds (7-10) to (7-13) which are triarylamine compounds of the general formula (7).

[0128] FIG. 64 is a view showing the structural formulas of Compounds (7-14) to (7-17) which are triarylamine compounds of the general formula (7).

MODE FOR CARRYING OUT THE INVENTION

[0129] The organic EL device of the present invention has a basic structure in which an anode, a hole transport layer, a luminous layer, an electron transport layer, and a cathode are provided in this sequence on a substrate such as a glass substrate or a transparent plastic substrate (e.g., polyethylene terephthalate substrate). As long as it has such a basic structure, its layer structure can take various forms. For example, an electron blocking layer can be provided between the hole transport layer and the luminous layer, a hole blocking layer can be provided between the luminous layer and the electron transport layer, or an electron injection layer can be provided between the electron transport layer and the cathode. Moreover, some of the organic layers can be omitted, or can be allowed to concurrently serve as the other layers. For example, a layer concurrently serving as the hole injection layer and the hole transport layer can be formed, or a layer concurrently serving as the electron injection layer and the electron transport layer can be formed. Furthermore, a configuration in which two or more of the organic layers having the same function are laminated can be adopted. Concretely, it is also possible to adopt a configuration in which two of the hole transport layers are laminated, a configuration in which two of the luminous layers are laminated, or a configuration in which two of the electron transport layers are laminated. In the present invention, it is preferred to configure the hole transport layer to have two layers laminated together, i.e., a first hole transport layer and a second hole transport layer. FIG. 1, for example, shows the layer configuration adopted in the Examples to be described later. In this layer configuration, a transparent anode 2, a hole injection layer 3, a hole transport layer 5, a luminous layer 6, an electron transport layer 7, an electron injection layer 8, and a cathode 9 are formed in this sequence on a glass substrate 1, the hole transport layer 5 being composed of two layers, a first hole transport layer 5a and a second hole transport layer 5b.

[0130] The respective layers constituting the organic EL device of the present invention will be described below.

[0131] The anode 2 is formed on the transparent substrate 1 by vapor deposition of an electrode material having a high work function, such as ITO or gold.

[0132] The hole injection layer 3 may be provided, if necessary, between the anode 2 and the hole transport layer 5. For the hole injection layer 3, a publicly known material can be used, for example, triphenylamine derivatives of starburst type; various triphenylamine tetramers; porphyrin compounds typified by copper phthalocyanine; acceptor type heterocyclic compounds such as hexacyanoazatriphenylene; and coating type polymeric materials. Moreover, arylamine compounds of the general formula (1) to be described later, triarylamine compounds of the general formula (6) to be described later, or triarylamine compounds of the general formula (7) to be described later can also be used. For the hole injection layer 3, it is preferred to use the triarylamine compounds of the general formula (6) or the general formula (7), because these (tri)arylamine compounds have high hole mobility. If the (tri)arylamine compounds of the general formula (1), (6) or (7) are used for the hole injection layer 3, however, the composition of the hole injection layer 3 and the composition of the hole transport layer 5 must be different.

[0133] Any of these materials may be subjected singly to film formation, but may be mixed with other materials and subjected to film formation. Materials p-doped with tris(bromophenyl)aminium hexachloroantimonate, radialene derivatives (see WO2014/009310) or the like, or polymeric compounds containing the structures of benzidine derivatives such as TPD in their partial structures may also be used.

[0134] When thin film formation is performed by a publicly known method such as vapor deposition, a spin coat method or an ink jet method with the use of any of the above materials, the hole injection layer 3 can be obtained. Each of the layers to be described below can similarly be obtained by film formation performed using a publicly known method such as vapor deposition, spin coating, or ink jetting.

[0135] The hole transport layer 5 is provided between the above anode 2 and the luminous layer 6. In the present invention, this hole transport layer 5 contains an arylamine compound represented by the following general formula (1) (may herein be referred to simply as an “arylamine compound of the general formula (1)”). This is because the arylamine compound of the general formula (1) has high hole mobility, and can thus increase the efficiency of hole transport from the hole transport layer to the luminous layer.

Arylamine compound of the general formula (1):

##STR00009##

[0136] In the general formula (1), Ar.sup.1 to Ar.sup.4 each represent an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group. Examples of the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.1 to Ar.sup.4, include a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridyl group, a pyrimidinyl group, a triazinyl group, a furyl group, a pyrrolyl group, a thienyl group, a quinolyl group, an isoquinolyl group, a quinazolinyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzimidazolyl group, a benzoxazolyl group, a benzothiazolyl group, a pyridopyrimidinyl group, a naphthyridinyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a naphthopyrimidinyl group, a dibenzofuranyl group, a dibenzothienyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, a carbolinyl group, a benzoquinazolinyl group and the like.

[0137] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.1 to Ar.sup.4, may each be unsubstituted, but may each have a substituent. The substituent can be exemplified by the following groups, in addition to a deuterium atom, a cyano group, and a nitro group:

[0138] a halogen atom, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or the like;

[0139] an alkyl group having 1 to 6 carbon atoms, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a neopentyl group, an n-hexyl group or the like;

[0140] an alkyloxy group having 1 to 6 carbon atoms, for example, a methyloxy group, an ethyloxy group, a propyloxy group or the like;

[0141] an alkenyl group, for example, a vinyl group, an allyl group or the like;

[0142] an aryloxy group, for example, a phenyloxy group, a tolyloxy group or the like;

[0143] an arylalkyloxy group, for example, a benzyloxy group, a phenethyloxy group or the like;

[0144] an aromatic hydrocarbon group or a condensed polycyclic aromatic group, for example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group or the like;

[0145] an aromatic heterocyclic group, for example, a pyridyl group, a pyrimidinyl group, a triazinyl group, a thienyl group, a furyl group, a pyrrolyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, a carbolinyl group or the like;

[0146] an arylvinyl group, for example, a styryl group, a naphthylvinyl group or the like; and

[0147] an acyl group, for example, an acetyl group, a benzoyl group or the like;

The alkyl group having 1 to 6 carbon atoms, the alkyloxy group having 1 to 6 carbon atoms, and the alkenyl group may be straight-chain or branched. Any of the above exemplary substituents may be further substituted by the above exemplary substituent. The above exemplary substituents may be present independently of each other in order to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

[0148] As Ar.sup.1 to Ar.sup.4, an aromatic hydrocarbon group, an oxygen-containing aromatic heterocyclic group, or a condensed polycyclic aromatic group is preferred, and a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, a phenanthrenyl group, a triphenylenyl group, a fluorenyl group, or a dibenzofuranyl group is more preferred.

[0149] As the substituent that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 may have, a deuterium atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aromatic hydrocarbon group, an oxygen-containing aromatic heterocyclic group, or a condensed polycyclic aromatic group is preferred, and a deuterium atom, a phenyl group, a biphenylyl group, a naphthyl group, a dibenzofuranyl group, or a vinyl group is more preferred. An embodiment in which Ar.sup.1 to Ar.sup.4 bind to each other via a single bond to form a condensed aromatic ring is also preferred.

[0150] An embodiment in which Ar.sup.1 and Ar.sup.2 are different groups, or Ar.sup.3 and Ar.sup.4 are different groups is preferred, and an embodiment in which Ar.sup.1 and Ar.sup.2 are different groups, and Ar.sup.3 and Ar.sup.4 are different groups is more preferred. The term “different” includes not only a case in which the basic structures are different, but also a case in which the basic structures are the same, but substituents are different, and a case in which the basic structures and the substituents are the same, but the positions of the substituents are different.

[0151] As the mode of binding of the phenylene groups in the general formula (1), a skeleton in which all the bonds are 1,4-bonds (e.g., 4,4″-diamino-[1,1′:4′,1″ ]terphenyl skeleton) is not preferred, but a skeleton containing 1,2-bonds or 1,3-bonds is preferred, from the viewpoint of thin film stability which influences the device life. That is, a skeleton in which the phenylene groups are not linearly linked, as shown below, is preferred: [0152] 4,4″-diamino-[1,1′: 3′,1″]terphenyl skeleton; [0153] 3,3″-diamino-[1,1′: 3′,1″]terphenyl skeleton; [0154] 2,2″-diamino-[1,1′: 3′,1″]terphenyl skeleton; [0155] 4,4″-diamino-[1,1′: 2′,1″]terphenyl skeleton; [0156] 3,3″-diamino-[1,1′: 2′,1″]terphenyl skeleton; [0157] 2,2″-diamino-[1,1′: 2′,1″]terphenyl skeleton; [0158] 2,4″-diamino-[1,1′: 4′,1″]terphenyl skeleton; [0159] 2,2″-diamino-[1,1′: 4′,1″]terphenyl skeleton; [0160] 3,3″-diamino-[1,1′: 4′,1″]terphenyl skeleton.

[0161] Particularly, an arylamine compound represented by the following general formula (1a-a), (1a-b), (1b-a), (1c-a), (1c-b) or (1c-c) is preferred.

##STR00010##

[0162] where Ar.sup.1 to Ar.sup.4 have the meanings as defined in the general formula (1).

[0163] Concrete examples of the preferred compounds among the arylamine compounds represented by the general formula (1) are shown in FIGS. 2 to 19, but such arylamine compounds are not limited to these compounds. D in the structural formulas denotes deuterium.

[0164] Of the exemplary compounds shown in FIGS. 2 to 19, the compounds corresponding to the formula (1a-a) are (1-1) to (1-3), (1-5) to (1-7), (1-9) to (1-10), (1-12), (1-14), (1-18) to (1-20), (1-25) to (1-26), (1-28), (1-33) to (1-34), (1-45), (1-94) to (1-97) and (1-104). The compounds corresponding to the formula (1a-b) are (1-15), (1-40), (1-43) to (1-44) and (1-47). The compounds corresponding to the formula (1b-a) are (1-23), (1-38) to (1-39), (1-41) to (1-42) and (1-103). The compounds corresponding to the formula (1c-a) are (1-24), (1-27), (1-30) to (1-32), (1-35) to (1-37), (1-93) and (1-99) to (1-100). The compounds corresponding to the formula (1c-b) are (1-22), (1-29), (1-46), (1-48) to (1-65), (1-98) and (1-105) The compound corresponding to the formula (1c-c) is (1-21).

[0165] The arylamine compound represented by the above general formula (1) can be synthesized using a publicly known method such as Suzuki coupling.

[0166] The purification of the arylamine compound represented by the general formula (1) can be performed, for example, by purification using a column chromatograph, adsorption purification using silica gel, activated carbon, activated clay, or the like, recrystallization or crystallization using a solvent, or sublimation purification. Like the arylamine compounds represented by the general formula (1), the other compounds for use in the organic EL device of the present invention are also obtainable by purification using a column chromatograph, adsorption purification using silica gel, activated carbon, activated clay, or the like, or purification by recrystallization or crystallization using a solvent, followed by final sublimation purification. The identification of the compounds can be made by NMR analysis. As the physical properties, the glass transition temperature (Tg) and the work function can be measured.

[0167] The glass transition temperature (Tg) serves as an index to stability in a thin film state. The glass transition temperature (Tg) can be measured by a high sensitivity differential scanning calorimeter (DSC3100SA, produced by Bruker AXS K.K.) using a powder.

[0168] The work function serves as an index to hole transport properties. The work function can be measured by preparing a 100 nm thin film on an ITO substrate, and making a measurement using an ionization potential measuring device (PYS-202, produced by Sumitomo Heavy Industries, Ltd.).

[0169] The arylamine compound of the general formula (1) may be subjected singly to film formation, but may be mixed with other materials and subjected to film formation. The hole transporting material that can be mixed with or used in combination with the arylamine compound of the general formula (1) can be exemplified by the following:

[0170] benzidine derivatives, for example, [0171] N,N′-diphenyl-N,N′-di(m-tolyl)benzidine (TPD), [0172] N,N′-diphenyl-N,N′-di(a-naphthyl)benzidine (NPD), and [0173] N,N,N′,N′-tetrabiphenylylbenzidine;

[0174] 1,1-bis [4-(di-4-tolylamino)phenyl]cyclohexane (TAPC);

[0175] triarylamine compounds which have two triarylamine structures in the molecule, and in which the triarylamine structures are linked to each other via a divalent group containing no hetero-atom, or a single bond, for example,

[0176] triarylamine compounds represented by the general formula (6) to be described later;

[0177] triarylamine compounds which have four triarylamine structures in the molecule, and in which the triarylamine structures are linked to each other via divalent groups containing no hetero-atom, or single bonds, for example,

[0178] triarylamine compounds represented by the general formula (7) to be described later; and

[0179] various triphenylamine trimers.

[0180] Furthermore, materials p-doped with tris(bromophenyl)aminium hexachloroantimonate, radialene derivatives (see WO2014/009310) or the like, or polymeric compounds containing the structures of benzidine derivatives such as TPD in their partial structures may also be used in combination.

[0181] In the present invention, the hole transport layer 5 preferably has a two-layer structure composed of the first hole transport layer 5a located on a side of the anode 2 and the second hole transport layer 5b located on a side of the luminous layer 6, for example, as shown in FIG. 1. The hole transport layer 5 with such a two-layer structure will be described later.

[0182] In the present invention, it is important for the luminous layer 6 to contain an indenoindole derivative represented by the following general formula (2) (may herein be referred to simply as an “indenoindole derivative of the general formula (2)”), or a carbazole derivative represented by the following general formula (3) (may herein be referred to simply as a “carbazole derivative of the general formula (3)”).

[0183] Indenoindole derivative of the general formula (2)

##STR00011##

(A.SUP.1.)

[0184] In the general formula (2), A.sup.1 represents a divalent group of an aromatic hydrocarbon, a divalent group of an aromatic heterocycle, a divalent group of a condensed polycyclic aromatic ring, or a single bond. The divalent group of an aromatic hydrocarbon, the divalent group of an aromatic heterocycle, or the divalent group of a condensed polycyclic aromatic ring, represented by A.sup.1, is a divalent group formed by removing two hydrogen atoms from an aromatic hydrocarbon, an aromatic heterocycle, or a condensed polycyclic aromatic ring. Examples of the aromatic hydrocarbon, the aromatic heterocycle, or the condensed polycyclic aromatic ring include benzene, biphenyl, terphenyl, tetrakisphenyl, styrene, naphthalene, anthracene, acenaphthalene, fluorene, phenanthrene, indane, pyrene, triphenylene, pyridine, pyrimidine, triazine, pyrrole, furan, thiophene, quinoline, isoquinoline, benzofuran, benzothiophene, indoline, carbazole, carboline, benzoxazole, benzothiazole, quinoxaline, benzimidazole, pyrazole, dibenzofuran, dibenzothiophene, naphthyridine, phenanthroline, and acridine.

[0185] The divalent group of an aromatic hydrocarbon, the divalent group of an aromatic heterocycle, or the divalent group of a condensed polycyclic aromatic ring, represented by A.sup.1, may be unsubstituted or may have a substituent. Examples of the substituent are the same as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0186] As A.sup.1, the divalent group of an aromatic hydrocarbon, the divalent group of a condensed polycyclic aromatic ring, or a single bond is preferred; a divalent group formed by removing two hydrogen atoms from benzene, biphenyl or naphthalene, or a single bond, is more preferred; and a divalent group formed by removing two hydrogen atoms from benzene, or a single bond, is particularly preferred.

(Ar.SUP.5.)

[0187] In the general formula (2), Ar.sup.5 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group. The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.5, can be the same as those exemplified in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the aforementioned general formula (1).

[0188] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.5, may be unsubstituted, but may have a substituent. Examples of the substituent are the same as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0189] As Ar.sup.5, a phenyl group, a biphenylyl group, a naphthyl group, or an aromatic heterocyclic group is preferred, and an aromatic heterocyclic group is particularly preferred. Of the aromatic heterocyclic groups, a triazinyl group, a quinazolinyl group, a naphthopyrimidinyl group, a benzimidazolyl group, a pyridopyrimidinyl group, a naphthyridinyl group, a pyridyl group, a quinolyl group, and an isoquinolyl group are particularly preferred.

(R.sup.1 to R.sup.8)

[0190] In the general formula (2), R.sup.1 to R.sup.8 each represent a hydrogen atom; a deuterium atom; a fluorine atom; a chlorine atom; a cyano group; a nitro group; an alkyl group having 1 to 6 carbon atoms; a cycloalkyl group having 5 to 10 carbon atoms; an alkenyl group having 2 to 6 carbon atoms; an alkyloxy group having 1 to 6 carbon atoms; a cycloalkyloxy group having 5 to 10 carbon atoms; an aromatic hydrocarbon group; an aromatic heterocyclic group; a condensed polycyclic aromatic group; an aryloxyl group; or a di-substituted amino group having an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group as a substituent. The alkyl group having 1 to 6 carbon atoms, the alkenyl group having 2 to 6 carbon atoms, or the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched.

[0191] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.1 to R.sup.8, can be exemplified by a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a neopentyl group, an n-hexyl group, a cyclopentyl group, a cyclohexyl group, a 1-adamantyl group, a 2-adamantyl group, a vinyl group, an allyl group, an isopropenyl group, a 2-butenyl group and the like.

[0192] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.1 to R.sup.8, may be unsubstituted, but may have a substituent. The substituent can be exemplified by the following groups, in addition to a deuterium atom, a cyano group, and a nitro group:

[0193] a halogen atom, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or the like;

[0194] an alkyloxy group having 1 to 6 carbon atoms, for example, a methyloxy group, an ethyloxy group, a propyloxy group or the like;

[0195] an alkenyl group, for example, a vinyl group, an allyl group or the like;

[0196] an aryloxy group, for example, a phenyloxy group, a tolyloxy group or the like;

[0197] an arylalkyloxy group, for example, a benzyloxy group, a phenethyloxy group or the like;

[0198] an aromatic hydrocarbon group or a condensed polycyclic aromatic group, for example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group or the like;

[0199] an aromatic heterocyclic group, for example, a pyridyl group, a pyrimidinyl group, a triazinyl group, a thienyl group, a furyl group, a pyrrolyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, a carbolinyl group or the like;

[0200] a di-substituted amino group substituted by an aromatic hydrocarbon group, for example, a diphenylamino group;

[0201] a di-substituted amino group substituted by a condensed polycyclic aromatic group, for example, a dinaphthylamino group or the like;

[0202] a di-substituted amino group substituted by an aromatic heterocyclic group, for example, a dipyridylamino group, a dithienylamino group or the like; and

[0203] a di-substituted amino group substituted by a substituent selected from an aromatic hydrocarbon group, a condensed polycyclic aromatic group, and an aromatic heterocyclic group. The alkenyl group and the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched. Any of the above exemplary substituents may be further substituted by the above exemplary substituent. The above exemplary substituents may be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

[0204] The alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.1 to R.sup.8, can be exemplified by a methyloxy group, an ethyloxy group, an n-propyloxy group, an isopropyloxy group, an n-butyloxy group, a tert-butyloxy group, an n-pentyloxy group, an n-hexyloxy group, a cyclopentyloxy group, a cyclohexyloxy group, a cycloheptyloxy group, a cyclooctyloxy group, a 1-adamantyloxy group, a 2-adamantyloxy group and the like.

[0205] The alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.1 to R.sup.8, may be unsubstituted, but may have a substituent. Examples of the substituent are the same as those shown as the substituents that the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.1 to R.sup.8 in the general formula (2) may have. The same holds true of the embodiments that the substituents can adopt.

[0206] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by R.sup.1 to R.sup.8, can be the same as those exemplified in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the aforementioned general formula (1). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0207] The aryloxy group represented by R.sup.1 to R.sup.8 can be exemplified by a phenyloxy group, a biphenylyloxy group, a terphenylyloxy group, a naphthyloxy group, an anthracenyloxy group, a phenanthrenyloxy group, a fluorenyloxy group, an indenyloxy group, a pyrenyloxy group, a perylenyloxy group and the like.

[0208] The aryloxy group represented by R.sup.1 to R.sup.8 may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0209] The aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group in the “di-substituted amino group having an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group as a substituent,” represented by R.sup.1 to R.sup.8, can be the same ones as those exemplified in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1). The di-substituted amino group, represented by R.sup.1 to R.sup.8, may be unsubstituted, but may further have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0210] It is not necessary for R.sup.1 to R.sup.4 to be present independently of each other to avoid formation of a ring. However, like Compound 2-14 or Compound 2-15 in FIG. 22, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. Similarly, it is not necessary for R.sup.5 to R.sup.8 to be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. Moreover, like Compound 2-1 to Compound 2-5 in FIG. 20, part of R.sup.1 to R.sup.4 may be detached, and remaining group of R.sup.1 to R.sup.4 may be bonded to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring. Likewise, part of R.sup.5 to R.sup.8 may be detached, and remaining group of R.sup.5 to R.sup.8 may be bonded to a vacancy, produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring.

[0211] An embodiment in which R.sup.1 to R.sup.8 together form a ring, and the group contributing to ring formation is a di-substituted amino group, as mentioned above, includes an embodiment in which R.sup.1 to R.sup.8 bind to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring. The above embodiment also includes an embodiment in which part of R.sup.1 to R.sup.4 is detached, and remaining group of R.sup.1 to R.sup.4 (i.e., di-substituted amino group) binds to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring. The above-mentioned embodiment further includes an embodiment in which part of R.sup.5 to R.sup.8 is detached, and remaining group of R.sup.5 to R.sup.8 (i.e., di-substituted amino group) binds to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring.

[0212] The aryl group in the monoarylamino group playing the role of a linking group for ring formation can be the same ones as those exemplified in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1). These groups may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0213] Preferred as the embodiment of the indenoindole derivative of the general formula (2) is an embodiment in which one of R.sup.1 to R.sup.4 is an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and the group binds to the benzene ring to which R.sup.1 to R.sup.4 are bound via a linking group, such as a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring. The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group preferred in this case is a phenyl group, an indenyl group, an indolyl group, a benzofuranyl group, or a benzothienyl group. In a preferred embodiment, the group, together with the benzene ring to which R.sup.1 to R.sup.4 are bound, form a fluorene ring, a carbazole ring, a dibenzofuran ring, a dibenzothiophene ring, an indenoindole ring, an indenobenzofuran ring, an indenobenzothiophene ring, a benzofuroindole ring, a benzothienoindole ring, or an indoloindole ring. Of these embodiments, the embodiments represented by the general formulas (2a) to (2c) indicated below, in particular, are preferred.

[0214] Also preferred is an embodiment in which the adjacent two of R.sup.1 to R.sup.4 are each an alkenyl group having 2 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and the adjacent two groups (R.sup.1 to R.sup.4) bind to each other via a single bond, and these groups, together with the benzene ring to which R.sup.1 to R.sup.4 are bound, form a condensed ring. The alkenyl group having 2 to 6 carbon atoms, aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group preferred in this case is a vinyl group or a phenyl group. That is, in a preferred embodiment, these groups, together with the benzene ring to which R.sup.1 to R.sup.4 are bound, form a naphthalene ring, a phenanthrene ring, or a triphenylene ring. Of these embodiments, the embodiment represented by the following general formula (2d) or (2e), in particular, is preferred.

##STR00012##

[0215] where X represents a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, and A.sup.1, Ar.sup.5 and R.sup.1 to R.sup.10 have the meanings as indicated in the general formula (2).

[0216] Similarly preferred is an embodiment in which the adjacent two of, or all of, R.sup.5 to R.sup.8 are each a vinyl group, and the adjacent two vinyl groups bind to each other via a single bond to form a condensed ring, that is, an embodiment in which they form a naphthalene ring or a phenanthrene ring, together with the benzene ring to which R.sup.5 to R.sup.8 are bound.

(R.sup.9, R.sup.10)

[0217] In the general formula (2), R.sup.9 and R.sup.10 each represent an alkyl group having 1 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group. The alkyl group having 1 to 6 carbon atoms may be straight-chain or branched.

[0218] The alkyl group having 1 to 6 carbon atoms, represented by R.sup.9 and R.sup.10, can be exemplified by the same ones as those shown in connection with the alkyl group having 1 to 6 carbon atoms represented by R.sup.1 to R.sup.8 in the general formula (2). The alkyl group having 1 to 6 carbon atoms, represented by R.sup.9 and R.sup.10, may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents optionally possessed by the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.1 to R.sup.8 in the general formula (2). The same holds true of the embodiments that the substituents can adopt.

[0219] The aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group, represented by R.sup.9 and R.sup.10, can be exemplified by the same ones as those shown in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1). These substituents may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0220] As R.sup.9, R.sup.10, an alkyl group having 1 to 6 carbon atoms is preferred, and a methyl group is particularly preferred.

[0221] It is not necessary for R.sup.9, R.sup.10 to be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

Carbazole derivative of the general formula (3)

##STR00013##

(A.SUP.2.)

[0222] In the general formula (3), A.sup.2 represents a divalent group of an aromatic hydrocarbon, a divalent group of an aromatic heterocycle, a divalent group of a condensed polycyclic aromatic ring, or a single bond. The divalent group of an aromatic hydrocarbon, the divalent group of an aromatic heterocycle, or the divalent group of a condensed polycyclic aromatic ring, represented by A.sup.2, can be exemplified by the same ones as those shown in connection with the divalent group of an aromatic hydrocarbon, the divalent group of an aromatic heterocycle, or the divalent group of a condensed polycyclic aromatic ring, represented by A.sup.1 in the general formula (2). These divalent groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0223] As A.sup.2, the divalent group of an aromatic hydrocarbon, the divalent group of a condensed polycyclic aromatic ring, or a single bond is preferred; a divalent group formed by removing two hydrogen atoms from benzene, biphenyl or naphthalene, or a single bond, is more preferred; and a divalent group formed by removing two hydrogen atoms from benzene, or a single bond, is particularly preferred.

(Ar.SUP.6.)

[0224] In the general formula (3), Ar.sup.6 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group. The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.6, can be exemplified by the same ones as those shown in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the aforementioned general formula (1). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0225] As Ar.sup.6, a phenyl group, a biphenylyl group, a naphthyl group, or an aromatic heterocyclic group is preferred, and an aromatic heterocyclic group is particularly preferred. Of the aromatic heterocyclic groups, a triazinyl group, a quinazolinyl group, a naphthopyrimidinyl group, a benzimidazolyl group, a pyridopyrimidinyl group, a naphthyridinyl group, a pyridyl group, a quinolyl group, and an isoquinolyl group are particularly preferred.

(R.sup.11 to R.sup.18)

[0226] In the general formula (3), R.sup.11 to R.sup.18 each represent a hydrogen atom; a deuterium atom; a fluorine atom; a chlorine atom; a cyano group; a nitro group; an alkyl group having 1 to 6 carbon atoms; a cycloalkyl group having 5 to 10 carbon atoms; an alkenyl group having 2 to 6 carbon atoms; an alkyloxy group having 1 to 6 carbon atoms; a cycloalkyloxy group having 5 to 10 carbon atoms; an aromatic hydrocarbon group; an aromatic heterocyclic group; a condensed polycyclic aromatic group; an aryloxyl group; or a di-substituted amino group having an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group as a substituent. The alkyl group having 1 to 6 carbon atoms, the alkenyl group having 2 to 6 carbon atoms, or the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched.

[0227] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.11 to R.sup.18, can be exemplified by the same ones as those shown in connection with the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms represented by R.sup.1 to R.sup.8 in the general formula (2). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms represented by R.sup.1 to R.sup.8 in the general formula (2) may have. The same holds true of the embodiments that the substituents can adopt.

[0228] The alkyloxy group having 1 to 6 carbon atoms, or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.11 to R.sup.18, can be exemplified by the same ones as those shown in connection with the alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.1 to R.sup.8 in the general formula (2). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms represented by R.sup.1 to R.sup.8 in the general formula (2) may have. The same holds true of the embodiments that the substituents can adopt.

[0229] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by R.sup.11 to R.sup.18, can be exemplified by the same ones as those shown in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by R.sup.1 to R.sup.8 in the aforementioned general formula (2). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0230] The aryloxy group represented by R.sup.11 to R.sup.18 can be exemplified by the same ones as those shown in connection with the aryloxy group represented by R.sup.1 to R.sup.8 in the general formula (2). The aryloxy group represented by R.sup.11 to R.sup.18 may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0231] The di-substituted amino group, represented by R.sup.11 to R.sup.18, can be exemplified by the same ones as those shown in connection with the di-substituted amino group represented by R.sup.1 to R.sup.8 in the general formula (2). The di-substituted amino group, represented by R.sup.11 to R.sup.18, may be unsubstituted, but may further have a substituent. The substituent optionally possessed further can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0232] It is not necessary for R.sup.11 to R.sup.14 to be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. Similarly, it is not necessary for R.sup.15 to R.sup.18 to be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. Moreover, like Compound 3-1 to Compound 3-6 in FIG. 23, part of R.sup.1 to R.sup.14 may be detached, and remaining group of R.sup.11 to R.sup.14 may be bonded to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring. Likewise, part of R.sup.15 to R.sup.18 may be detached, and remaining group of R.sup.15 to R.sup.18 may be bonded to a vacancy, produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group to form a ring.

[0233] An embodiment in which R.sup.11 to R.sup.18 together form a ring, and the group contributing to ring formation is a di-substituted amino group, as mentioned above, includes an embodiment in which R.sup.11 to R.sup.18 bind to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring. The above embodiment also includes an embodiment in which part of R.sup.11 to R.sup.14 is detached, and remaining group of R.sup.11 to R.sup.14 (i.e., di-substituted amino group) binds to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring. The above-mentioned embodiment further includes an embodiment in which part of R.sup.15 to R.sup.18 is detached, and remaining group of R.sup.15 to R.sup.18 (i.e., di-substituted amino group) binds to a vacancy, which has been produced by the detachment, via a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, while being mediated by the aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group possessed by the di-substituted amino group, to form a ring.

[0234] The monoarylamino group playing the role of a linking group for ring formation can be exemplified by the same one as the monoarylamino group as the linking group in the general formula (2). The monoarylamino group may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0235] Preferred as the embodiment of the carbazole derivative of the general formula (3) is an embodiment in which the adjacent two of R.sup.15 to R.sup.18 are each an alkenyl group having 2 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and the adjacent two groups (R.sup.15 to R.sup.18) bind to each other via a single bond and, together with the benzene ring to which R.sup.15 to R.sup.18 are bound, and form a condensed ring. The alkenyl group having 2 to 6 carbon atoms, aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group preferred in this case is a vinyl group or a phenyl group. That is, in a preferred embodiment, these groups, together with the benzene ring to which R.sup.15 to R.sup.18 are bound, form a naphthalene ring, a phenanthrene ring, or a triphenylene ring.

[0236] Also preferred is an embodiment in which one of R.sup.11 to R.sup.14 is an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group, and the group binds to the benzene ring to which R.sup.11 to R.sup.14 are bound via a linking group, such as a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, to form a ring. The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group preferred in this case is a phenyl group, an indenyl group, an indolyl group, a benzofuranyl group, or a benzothienyl group. Particularly preferred as such an embodiment in which R.sup.1 to R.sup.14 and the benzene ring, to which R.sup.11 to R.sup.14 are bound, bind together to form a ring is an embodiment represented by the general formula (3a-1), (3a-2), (3a-3), (3a-4) or (3b-1) shown below. Concretely, it is preferred that R.sup.11 to R.sup.14 and the benzene ring, to which R.sup.11 to R.sup.14 are bound, together form a fluorene ring, a carbazole ring, a dibenzofuran ring, a dibenzothiophene ring, an indenoindole ring, an indenobenzofuran ring, an indenobenzothiophene ring, a benzofuroindole ring, a benzothienoindole ring, or an indoloindole ring.

##STR00014##

[0237] where X represents a substituted or unsubstituted methylene group, an oxygen atom, a sulfur atom, or a monoarylamino group, and A.sup.2, Ar.sup.6 and R.sup.11 to R.sup.18 have the meanings as indicated in the general formula (3).

[0238] Also preferred is an embodiment in which the adjacent two of, or all of, R.sup.11 to R.sup.14 are each a vinyl group, and the adjacent two vinyl groups bind to each other via a single bond to form a condensed ring, that is, an embodiment in which they form a naphthalene ring or a phenanthrene ring, together with the benzene ring to which R.sup.11 to R.sup.14 are bound.

[0239] An embodiment in which one of R.sup.15 to R.sup.18 is an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group is also preferred. More preferably, one of R.sup.15 to R.sup.18 is a group selected from a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothienyl group. Particularly preferably, R.sup.16 is a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, or a dibenzothienyl group, and R.sup.15, R.sup.17 and R.sup.18 are each a hydrogen atom.

[0240] Examples of the preferred compounds among the indenoindole derivatives of the general formula (2) are shown in FIGS. 20 to 22. However, the indenoindole derivatives of the general formula (2) are not limited to these exemplary compounds.

[0241] Of the exemplary compounds in FIGS. 20 to 22, the compounds corresponding to the formula (2a) are (2-1) to (2-4) and (2-9) to (2-10). The compounds corresponding to the formula (2b) are (2-5) to (2-6) and (2-11) to (2-12). The compounds corresponding to the formula (2c) are (2-7) to (2-8). The compound corresponding to the formula (2d) is (2-14). The compound corresponding to the formula (2e) is (2-15).

[0242] Examples of the preferred compounds among the carbazole derivatives of the general formula (3) are shown in FIGS. 23 to 26. However, the carbazole derivatives of the general formula (3) are not limited to these exemplary compounds.

[0243] Of the exemplary compounds in FIGS. 23 to 26, the compounds corresponding to the formula (3a-1) are (3-1) to (3-6), (3-8) to (3-10), (3-12) and (3-15). The compound corresponding to the formula (3a-2) is (3-14). The compound corresponding to the formula (3a-3) is (3-7). The compound corresponding to the formula (3a-4) is (3-11). The compound corresponding to the formula (3b-1) is (3-13).

[0244] The indenoindole derivatives of the general formula (2) and the carbazole derivatives of the general formula (3), mentioned above, can be synthesized in accordance with publicly known methods (see Patent Document 6).

[0245] The indenoindole derivatives of the general formula (2) and the carbazole derivatives of the general formula (3) are compounds excellent in luminous efficiency as compared with conventional materials, and they are preferred as host materials for the luminous layer, in particular, as host materials for the luminous layer containing phosphorescent luminous materials.

[0246] For the luminous layer in the organic EL device of the present invention, publicly known luminous materials, such as various metal complexes, for example, metal complexes of quinolinol derivatives including Alq.sub.3; anthracene derivatives; bisstyrylbenzene derivatives; pyrene derivatives; oxazole derivatives; and polyparaphenylenevinylene derivatives, can be used in combination, as far as they do not impair the excellent characteristics of the indenoindole derivatives of the general formula (2) or the carbazole derivatives of the general formula (3).

[0247] In the present invention, the luminous layer may be composed of a host material and a dopant material. Examples of the host material include the indenoindole derivatives of the general formula (2); the carbazole derivatives of the general formula (3); the aforementioned luminous materials; thiazole derivatives; benzimidazole derivatives; and polydialkylfluorene derivatives. Preferred are the indenoindole derivatives of the general formula (2), or the carbazole derivatives of the general formula (3).

[0248] As the dopant material, there can be used quinacridone, coumarin, rubrene, perylene, pyrene and derivatives thereof; benzopyran derivatives; indenophenanthrene derivatives; rhodamine derivatives; aminostyryl derivatives and the like.

[0249] Furthermore, a phosphorescent luminous material can be preferably used as the luminous material. As the phosphorescent luminous material, a phosphorescent luminous body in the form of a metal complex containing iridium, platinum or the like can be used. For example, a green phosphorescent luminous body such as Ir(ppy).sub.3; a blue phosphorescent luminous body such as FIrpic or FIr6; or a red phosphorescent luminous body such as Btp.sub.2Ir(acac) is used.

[0250] As the host material in this case, the indenoindole derivative of the general formula (2) or the carbazole derivative of the general formula (3) can be used. Moreover, use can be made of the following hole injecting/transporting host material:

[0251] a carbazole derivative, for example, [0252] 4,4′-di(N-carbazolyl)biphenyl (CBP), [0253] TCTA, or [0254] mCP.
The following electron transporting host material is also usable: [0255] p-bis(triphenylsilyl)benzene (UGH2); or [0256] 2,2′,2″-(1,3,5-phenylene)-tris(1-phenyl-1H-benzimidazole) (TPBI).
By using such a host material, a high performance organic EL device can be prepared.

[0257] Doping of the host material with the phosphorescent luminous material is preferably performed by codeposition in a range of 1 to 30% by weight based on the entire luminous layer in order to avoid concentration quenching.

[0258] In the present invention, moreover, a material which emits delayed fluorescence, such as a CDCB derivative, for example, PIC-TRZ, CC2TA, PXZ-TRZ, or 4CzIPN, can be used as the luminous material.

[0259] In the present invention, a red luminous material is used preferably as the luminous material to be combined with the indenoindole derivative of the general formula (2) or the carbazole derivative of the general formula (3).

[0260] In the present invention, the electron transport layer 7 is provided on the above-described luminous layer 6. The electron transport layer 7 may be formed from a publicly known electron transport material. For example, it may be formed from various metal complexes such as metal complexes of quinolinol derivatives including Alq.sub.3 and BAIq; triazole derivatives; triazine derivatives; oxadiazole derivatives; pyridine derivatives; anthracene derivatives; benzimidazole derivatives; thiadiazole derivatives; benzotriazole derivatives; carbodiimide derivatives; quinoxaline derivatives; pyridoindole derivatives; phenanthroline derivatives; and silole derivatives.

[0261] In the present invention, moreover, it is preferred that a pyrimidine derivative represented by the general formula (4) (may herein be referred to simply as a “pyrimidine derivative of the general formula (4)”) shown below be used as an electron transport material to form the electron transport layer. It is more preferred that a pyrimidine derivative represented by the general formula (4a) or (4b) shown below be used as an electron transport material to form the electron transport layer. Such a pyrimidine derivative is excellent in electron injecting and transporting capabilities, and also excels in thin film stability and durability. The electron transport layer containing such a pyrimidine derivative is improved in the efficiency of electron transport from the electron transport layer to the luminous layer.

##STR00015##

(Ar.sup.7 to Ar.sup.9)

[0262] In the general formulas (4), (4a) and (4b), Ar.sup.7 represents an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group; Ar.sup.8 and Ar.sup.9 each represent a hydrogen atom, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group; and Ar.sup.8 and Ar.sup.9 are each not a hydrogen atom at the same time.

[0263] Examples of the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.7 to Ar.sup.9, include a phenyl group, a biphenylyl group, a terphenylyl group, a tetrakisphenyl group, a styryl group, a naphthyl group, an anthracenyl group, an acenaphthenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, a furyl group, a thienyl group, a benzofuranyl group, a benzothienyl group, a dibenzofuranyl group, a dibenzothienyl group and the like.

[0264] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by Ar.sup.7 to Ar.sup.9, may each be unsubstituted, but may each have a substituent. The substituent can be exemplified by the following groups, in addition to a deuterium atom, a cyano group, and a nitro group:

[0265] a halogen atom, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or the like;

[0266] an alkyl group having 1 to 6 carbon atoms, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a neopentyl group, an n-hexyl group or the like;

[0267] an alkyloxy group having 1 to 6 carbon atoms, for example, a methyloxy group, an ethyloxy group, a propyloxy group or the like;

[0268] an alkenyl group, for example, a vinyl group, an allyl group or the like;

[0269] an aryloxy group, for example, a phenyloxy group, a tolyloxy group or the like;

[0270] an arylalkyloxy group, for example, a benzyloxy group, a phenethyloxy group or the like;

[0271] an aromatic hydrocarbon group or a condensed polycyclic aromatic group, for example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, an acenaphthenyl group or the like;

[0272] an aromatic heterocyclic group, for example, a pyridyl group, a thienyl group, a furyl group, a pyrrolyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, an azafluorenyl group, a diazafluorenyl group, a carbolinyl group, an azaspirobifluorenyl group, a diazaspirobifluorenyl group or the like;

[0273] an arylvinyl group, for example, a styryl group a naphthylvinyl group or the like; and

[0274] an acyl group, for example, an acetyl group, a benzoyl group or the like,

The alkyl group having 1 to 6 carbon atoms, the alkenyl group, and the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched. Any of the above exemplary substituents may be further substituted by the above exemplary substituent. The above exemplary substituents may be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. Further, these substituents and Ar.sup.7, Ar.sup.8 or Ar.sup.9, to which these substituents are bound, may be bonded to each other via an oxygen atom or a sulfur atom to form a ring.

[0275] Preferred as Ar.sup.7 is a phenyl group; a biphenylyl group; a naphthyl group; an anthracenyl group; an acenaphthenyl group; a phenanthrenyl group; a fluorenyl group; an indenyl group; a pyrenyl group; a perylenyl group; a fluoranthenyl group; a triphenylenyl group; a spirobifluorenyl group; an oxygen-containing aromatic heterocyclic group, for example, a furyl group, a benzofuranyl group, or a dibenzofuranyl group; or a sulfur-containing aromatic heterocyclic group, for example, a thienyl group, a benzothienyl group, or a dibenzothienyl group. More preferred as Ar.sup.7 is a phenyl group, a biphenylyl group, a naphthyl group, a phenanthrenyl group, a fluorenyl group, a pyrenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, a dibenzofuranyl group, or a dibenzothienyl group.

[0276] If Ar.sup.7 is a phenyl group, this phenyl group preferably has a substituted or unsubstituted condensed polycyclic aromatic group or phenyl group as a substituent, and more preferably has a substituent selected from a naphthyl group, a phenanthrenyl group, a pyrenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, and a phenyl group. Also preferably, the substituent possessed by the phenyl group and the phenyl group bind to each other via an oxygen atom or a sulfur atom to form a ring.

[0277] Preferred as Ar.sup.8 is a phenyl group having a substituent; a substituted or unsubstituted spirobifluorenyl group; an oxygen-containing aromatic heterocyclic group, for example, a furyl group, a benzofuranyl group, or a dibenzofuranyl group; or a sulfur-containing aromatic heterocyclic group, for example, a thienyl group, a benzothienyl group, or a dibenzothienyl group.

[0278] As the substituent for the phenyl group in this case, an aromatic hydrocarbon group, for example, a phenyl group, a biphenylyl group, or a terphenyl group; a condensed polycyclic aromatic group, for example, a naphthyl group, an acenaphthenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, or a spirobifluorenyl group; an oxygen-containing aromatic heterocyclic group, for example, a furyl group, a benzofuranyl group, or a dibenzofuranyl group; or a sulfur-containing aromatic heterocyclic group, for example, a thienyl group, a benzothienyl group, or a dibenzothienyl group; is preferred and, a phenyl group, a naphthyl group, a phenanthrenyl group, a fluorenyl group, a pyrenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, a dibenzofuranyl group, or a dibenzothienyl group is more preferred. It is also preferred that the substituent possessed by the phenyl group and the phenyl group bind to each other via an oxygen atom or a sulfur atom to form a ring.

[0279] Preferred as Ar.sup.9 is a hydrogen atom; a phenyl group having a substituent; a substituted or unsubstituted spirobifluorenyl group; an oxygen-containing aromatic heterocyclic group, for example, a furyl group, a benzofuranyl group, or a dibenzofuranyl group; or a sulfur-containing aromatic heterocyclic group, for example, a thienyl group, a benzothienyl group, or a dibenzothienyl group.

[0280] As the substituent for the phenyl group in this case, an aromatic hydrocarbon group, for example, a phenyl group, a biphenylyl group, or a terphenyl group; a condensed polycyclic aromatic group, for example, a naphthyl group, an acenaphthenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, or a spirobifluorenyl group; an oxygen-containing aromatic heterocyclic group, for example, a furyl group, a benzofuranyl group, or a dibenzofuranyl group; or a sulfur-containing aromatic heterocyclic group, for example, a thienyl group, a benzothienyl group, or a dibenzothienyl group; is preferred, and a phenyl group, a naphthyl group, a phenanthrenyl group, a fluorenyl group, a pyrenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, a dibenzofuranyl group, or a dibenzothienyl group is more preferred. It is also preferred that the substituent possessed by the phenyl group and the phenyl group bind to each other via an oxygen atom or a sulfur atom to form a ring.

[0281] It is preferred for one of Ar.sup.8 and Ar.sup.9 to be a hydrogen atom.

(B) In the above general formulas (4), (4a) and (4b), B represents a monovalent group represented by the structural formula (5) indicated below and, from the viewpoint of thin film stability, preferably represents a monovalent group represented by the structural formula (5a) indicated below. In the structural formula (5a), the position of binding of Ar.sup.10 in the benzene ring is the meta-position with respect to the position of binding to the pyrimidine ring represented by the general formula (4).

##STR00016##

[0282] In the structural formulas (5) and (5a), Ar.sup.10 represents an aromatic heterocyclic group. Examples of the aromatic heterocyclic group represented by Ar.sup.10 include a triazinyl group, a pyridyl group, a pyrimidinyl group, a furyl group, a pyrrolyl group, a thienyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, an azafluorenyl group, a diazafluorenyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, a carbolinyl group, an azaspirobifluorenyl group, a diazaspirobifluorenyl group and the like.

[0283] The aromatic heterocyclic group represented by Ar.sup.10 may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.7 to Ar.sup.9 in the general formula (4) may have. The same holds true of the embodiments that the substituents can adopt.

[0284] As Ar.sup.10, a nitrogen-containing heterocyclic group, for example, a triazinyl group, a pyridyl group, a pyrimidinyl group, a pyrrolyl group, a quinolyl group, an isoquinolyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, an azafluorenyl group, a diazafluorenyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, a carbolinyl group, an azaspirobifluorenyl group, or a diazaspirobifluorenyl group is preferred; a triazinyl group, a pyridyl group, a pyrimidinyl group, a quinolyl group, an isoquinolyl group, an indolyl group, a quinoxalinyl group, an azafluorenyl group, a diazafluorenyl group, a benzimidazolyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, an azaspirobifluorenyl group, or a diazaspirobifluorenyl group is more preferred; and a pyridyl group, a pyrimidinyl group, a quinolyl group, an isoquinolyl group, an indolyl group, an azafluorenyl group, a diazafluorenyl group, a quinoxalinyl group, a benzimidazolyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, an azaspirobifluorenyl group, or a diazaspirobifluorenyl group is particularly preferred.

[0285] In the structural formulas (5) and (5a), R.sup.19 to R.sup.22 each represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a cyano group, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, or a condensed polycyclic aromatic group. The alkyl group having 1 to 6 carbon atoms may be straight-chain or branched. R.sup.19 to R.sup.22 and Ar.sup.10 may be present independently of each other so as not to form a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

[0286] The alkyl group having 1 to 6 carbon atoms, represented by R.sup.19 to R.sup.22, can be exemplified by a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, a 2-methylpropyl group, a t-butyl group, an n-pentyl group, a 3-methylbutyl group, a tert-pentyl group, an n-hexyl group, an iso-hexyl group, a tert-hexyl group and the like.

[0287] The alkyl group having 1 to 6 carbon atoms, represented by R.sup.19 to R.sup.22, may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.1 to R.sup.8 in the general formula (2), may have. The same holds true of the embodiments that the substituents can adopt.

[0288] Examples of the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by R.sup.19 to R.sup.22, include a phenyl group, a biphenylyl group, a terphenylyl group, a tetrakisphenyl group, a styryl group, a naphthyl group, an anthracenyl group, an acenaphthenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group, a spirobifluorenyl group, a triazinyl group, a pyridyl group, a pyrimidinyl group, a furyl group, a pyrrolyl group, a thienyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, an azafluorenyl group, a diazafluorenyl group, a naphthyridinyl group, a phenanthrolinyl group, an acridinyl group, a carbolinyl group, a phenoxazinyl group, a phenothiazinyl group, a phenazinyl group, an azaspirobifluorenyl group, a diazaspirobifluorenyl group and the like.

[0289] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by R.sup.19 to R.sup.22, may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.7 to Ar.sup.9 in the general formula (4) may have. The same holds true of the embodiments that the substituents can adopt.

[0290] Concrete examples of the preferred compounds among the pyrimidine derivatives represented by the general formula (4) are shown in FIGS. 27 to 54. However, such pyrimidine derivatives are not limited to these exemplary compounds. D in the structural formulas represents a deuterium atom.

[0291] Of the exemplary compounds in FIGS. 27 to 54, the compounds corresponding to the formula (4a) are (4-1) to (4-49), (4-66) to (4-99), (4-103) to (4-105) and (4-107) to (4-126). The compounds corresponding to the formula (4b) are (4-50) to (4-65). The compounds in which the group B is a monovalent group represented by the structural formula (5a) are (4-1) to (4-66), (4-68), (4-71) to (4-72), (4-105) to (4-107) and (4-112) to (4-122).

[0292] The pyrimidine derivatives of the general formula (4), mentioned above, can be synthesized in accordance with a publicly known method (see Patent Document 7).

[0293] The above-described electron transport material may be subjected singly to film formation, but may be mixed with other materials and subjected to film formation.

[0294] The organic EL device of the present invention may have the electron injection layer 8 between the electron transport layer 7 and the cathode 9. The electron injection layer 8 may contain an alkali metal salt such as lithium fluoride or cesium fluoride; an alkaline earth metal salt such as magnesium fluoride; a metal oxide such as aluminum oxide or the like. However, such a material can be omitted in the suitable selection of the electron transport layer and the cathode.

[0295] In connection with the cathode 9 in the organic EL device of the present invention, a metal with a low work function such as aluminum, or an alloy having a lower work function, such as a magnesium-silver alloy, a magnesium-indium alloy, or an aluminum-magnesium alloy, is used as an electrode material.

[0296] The organic EL device of the present invention may have other layers, if desired. For example, an electron blocking layer can be provided between the hole transport layer 5 and the luminous layer 6, and a hole blocking layer can be provided between the luminous layer 6 and the electron transport layer 7, although they are not shown in FIG. 1.

Electron blocking layer:

[0297] For the electron blocking layer, publicly known compounds having electron blocking action can be used. As the publicly known compounds, the following can be exemplified:

[0298] carbazole derivatives, for example, [0299] 4,4′,4″-tri(N-carbazolyl)triphenylamine (TCTA); [0300] 9,9-bis[4-(carbazol-9-yl)phenyl]fluorene; [0301] 1,3-bis(carbazol-9-yl)benzene (mCP); and [0302] 2,2-bis(4-carbazol-9-ylphenyl)adamantane (Ad-Cz). compounds having a triphenylsilyl group and a triarylamine structure, for example, [0303] 9-[4-(carbazol-9-yl)phenyl]-9-[4-(triphenylsilyl) phenyl]-9H-fluorene.

[0304] For the electron blocking layer, the arylamine compound represented by the general formula (1) can be used suitably because of its high electron blocking performance. In this case, however, the composition of the electron blocking layer and the composition of the hole transport layer have to be different. These materials may be subjected singly to film formation, but may be mixed with other materials and subjected to film formation.

Hole Blocking Layer:

[0305] The hole blocking layer can use compounds having hole blocking action, such as phenanthroline derivatives, e.g., bathocuproine (BCP), metal complexes of quinolinol derivatives, e.g., aluminum(III) bis(2-methyl-8-quinolinate)-4-phenylphenolate (BAlq), various rare earth complexes, triazole derivatives, triazine derivatives, and oxadiazole derivatives. These materials may be subjected singly to film formation, but may be mixed with other materials and subjected to film formation. These materials may also concurrently serve as the materials for the electron transport layer.

[0306] Each layer constituting the organic EL device of the present invention may be structured in a single layer or in a plurality of layers. In the present invention, in particular, in order to exhibit the excellent characteristics of the arylamine compound of the general formula (1), it is preferred to structure the hole transport layer 5 in two layers, the first hole transport layer 5a and the second hole transport layer 5b as shown in FIG. 1. The hole transport layer 5 of the two-layer structure will be described below.

[0307] The organic EL device of the present invention uses the arylamine compound represented by the general formula (1) in forming the hole transport layer 5. The hole transport layer 5 containing such an arylamine compound is preferably configured as a two-layer structure. That is, as shown in FIG. 1, it is preferred that the hole transport layer 5 be configured to be of a two-layer structure in which it is divided into the first hole transport layer 5a located on a side of the anode 2, and the second hole transport layer 5b located on a side of the luminous layer 6.

[0308] In the second hole transport layer 5b, it is preferred to contain the arylamine compound of the general formula (1), because this compound shows high electron blocking performance. In this case, the aforementioned hole transporting material or the like can be used in combination with the arylamine compound of the general formula (1) for the second hole transport layer 5b.

[0309] The composition of the first hole transport layer 5a is different from the composition of the second hole transport layer 5b. Concretely, the first hole transport layer 5a can use, in addition to the above hole transporting material, a triarylamine compound which has 2 to 6 triarylamine structures in the molecule, and in which the triarylamine structures are linked to each other via a single bond, or a divalent group containing no hetero-atom, for example. This is because the arylamine skeleton shows excellent hole transporting properties.

[0310] Preferred as the above-mentioned triarylamine compound having 2 to 6 triarylamine structures is a triarylamine compound having 2 triarylamine structures, represented by the following general formula (6) (may herein be referred to simply as “triarylamine compound of the general formula (6)”), or a triarylamine compound having 4 triarylamine structures, represented by the following general formula (7) (may herein be referred to simply as “triarylamine compound of the general formula (7)”).

[0311] Triarylamine compound of the general formula (6);

##STR00017##

(r.sup.23 to r.sup.28) In the general formula (6), r.sup.23 to r.sup.28 are each an integer showing the number of the substituents R.sup.23's to the substituents R.sup.28's bound to each benzene ring, r.sup.23, r.sup.24, r.sup.27 and r.sup.28 each denote an integer of 0 to 5, and r.sup.25 and r.sup.26 each denote an integer of 0 to 4. As r.sup.23 to r.sup.28, an integer of 0 to 3 is preferred, and an integer of 0 to 2 is more preferred.

[0312] If r.sup.23 to r.sup.28 are each 0, this means that there are none of R.sup.23 to R.sup.28 on the benzene rings. That is, the benzene rings are not substituted by groups represented by R.sup.23 to R.sup.28.

[0313] If r.sup.23, r.sup.24, r.sup.27 and r.sup.28 are each an integer of 2 to 5, or if r.sup.25 and r.sup.26 are each an integer of 2 to 4, on the other hand, a plurality of the substituents R.sup.23's to the substituents R.sup.28's are bound to the same benzene ring. In this case, the plurality of the substituents present may be present independently of each other so as not to form a ring, but may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. For example, the plurality of substituents may be bound together to form a naphthalene ring, as in the exemplary compounds 6-13 and 6-14 in FIG. 57.

(R.sup.23 to R.sup.28)

[0314] In the general formula (6), R.sup.23 to R.sup.28 each represent a deuterium atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkyloxy group having 1 to 6 carbon atoms, a cycloalkyloxy group having 5 to 10 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, a condensed polycyclic aromatic group, or an aryloxy group. The alkyl group having 1 to 6 carbon atoms, the alkenyl group having 2 to 6 carbon atoms, and the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched.

[0315] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28, can be exemplified by a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a neopentyl group, an n-hexyl group, a cyclopentyl group, a cyclohexyl group, a 1-adamantyl group, a 2-adamantyl group, a vinyl group, an allyl group, an isopropenyl group, a 2-butenyl group and the like.

[0316] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28, may be unsubstituted, but may have a substituent. The substituent can be exemplified by the following groups, in addition to a deuterium atom, a cyano group, and a nitro group:

[0317] a halogen atom, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or the like;

[0318] an alkyloxy group having 1 to 6 carbon atoms, for example, a methyloxy group, an ethyloxy group, a propyloxy group or the like;

[0319] an alkenyl group, for example, a vinyl group, an allyl group or the like;

[0320] an aryloxy group, for example, a phenyloxy group, a tolyloxy group or the like;

[0321] an arylalkyloxy group, for example, a benzyloxy group, a phenethyloxy group or the like;

[0322] an aromatic hydrocarbon group or a condensed polycyclic aromatic group, for example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a fluorenyl group, an indenyl group, a pyrenyl group, a perylenyl group, a fluoranthenyl group, a triphenylenyl group or the like; and

[0323] an aromatic heterocyclic group, for example, a pyridyl group, a pyrimidinyl group, a triazinyl group, a thienyl group, a furyl group, a pyrrolyl group, a quinolyl group, an isoquinolyl group, a benzofuranyl group, a benzothienyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzothiazolyl group, a quinoxalinyl group, a benzimidazolyl group, a pyrazolyl group, a dibenzofuranyl group, a dibenzothienyl group, a carbolinyl group or the like; The alkenyl group and the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched. Any of the above exemplary substituents may be further substituted by the above exemplary substituent. The above exemplary substituents may be present independently of each other to avoid formation of a ring. However, they may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring.

[0324] The alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.23 to R.sup.28, can be exemplified by a methyloxy group, an ethyloxy group, an n-propyloxy group, an isopropyloxy group, an n-butyloxy group, a tert-butyloxy group, an n-pentyloxy group, an n-hexyloxy group, a cyclopentyloxy group, a cyclohexyloxy group, a cycloheptyloxy group, a cyclooctyloxy group, a 1-adamantyloxy group, a 2-adamantyloxy group and the like.

[0325] The alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.23 to R.sup.28, may be unsubstituted, but may have a substituent. Examples of the substituent are the same as those shown as the substituents that the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28 in the general formula (6), may have. The same holds true of the embodiments that the substituents can adopt.

[0326] The aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group, represented by R.sup.23 to R.sup.28, can be exemplified by the same ones as those shown in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the aforementioned general formula (1). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0327] The aryloxy group represented by R.sup.23 to R.sup.28 can be exemplified by a phenyloxy group, a biphenylyloxy group, a terphenylyloxy group, a naphthyloxy group, an anthracenyloxy group, a phenanthrenyloxy group, a fluorenyloxy group, an indenyloxy group, a pyrenyloxy group, a perylenyloxy group and the like.

[0328] The aryloxy group represented by R.sup.23 to R.sup.28 may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.l to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0329] As R.sup.23 to R.sup.28, a deuterium atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aromatic hydrocarbon group, or a condensed polycyclic aromatic group is preferred; and a deuterium atom, a phenyl group, a biphenylyl group, a naphthyl group, or a vinyl group is more preferred. It is also preferred for R.sup.23 to R.sup.28 to bind to each other via a single bond, thereby forming a condensed aromatic ring. Particularly, a deuterium atom, a phenyl group, or a biphenylyl group is preferred.

(L.SUP.1.)

[0330] In the general formula (6), L.sup.1 is a bridging group connecting the two triarylamine structures, and represents a single bond, or a divalent group represented by each of the following structural formulas (B) to (G):

##STR00018##

[0331] where n1 denotes an integer of 1 to 4.

[0332] As L.sup.1, the divalent group represented by the structural formula (B), (D) or (G), or a single bond, is preferred; and the divalent group represented by the structural formula (D) or (G), or a single bond, is more preferred. In the structural formula (B), n1 is preferably 1 or 2.

Triarylamine compound of the general formula (7);

##STR00019##

(r.sup.29 to r.sup.40)

[0333] In the general formula (7), r.sup.29 to r.sup.40 are each an integer showing the number of the groups R.sup.29's to the groups R.sup.40's bound to the respective benzene rings, r.sup.29, r.sup.30, r.sup.33, r.sup.36, r.sup.39 and r.sup.40 each denote an integer of 0 to 5, and r.sup.31, r.sup.32, r.sup.34, r.sup.35, r.sup.37 and r.sup.38 each denote an integer of 0 to 4. As r.sup.29 to r.sup.40, an integer of 0 to 3 is preferred, and an integer of 0 to 2 is more preferred.

[0334] If r.sup.29 to r.sup.40 are each 0, this means that there are none of R.sup.29 to R.sup.40 on the benzene rings. That is, the benzene rings are not substituted by groups represented by R.sup.29 to R.sup.40

[0335] If r.sup.29, r.sup.30, r.sup.33, r.sup.36, r.sup.39 and r.sup.40 are each an integer of 2 to 5, or if r.sup.31, r.sup.32, r.sup.34, r.sup.35, r.sup.37 and r.sup.38 are each an integer of 2 to 4, on the other hand, a plurality of the groups R.sup.29's to the groups R.sup.40's, respectively, are bound to the same benzene ring. In this case, a plurality of the substituents present may be present independently of each other so as not to form a ring, but may be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom, or a sulfur atom to form a ring. For example, the plurality of the substituents may be bound together to form a naphthalene ring, as in the exemplary compound 7-8 in FIG. 62.

(R.sup.29 to R.sup.40)

[0336] In the general formula (7), R.sup.29 to R.sup.40 each represent a deuterium atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 5 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkyloxy group having 1 to 6 carbon atoms, a cycloalkyloxy group having 5 to 10 carbon atoms, an aromatic hydrocarbon group, an aromatic heterocyclic group, a condensed polycyclic aromatic group, or an aryloxy group. The alkyl group having 1 to 6 carbon atoms, the alkenyl group having 2 to 6 carbon atoms, and the alkyloxy group having 1 to 6 carbon atoms may be straight-chain or branched.

[0337] The alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.29 to R.sup.40, can be exemplified by the same ones as those shown in connection with the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28 in the general formula (6). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents optionally possessed by the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28 in the general formula (6). The same holds true of the embodiments that the substituents can adopt.

[0338] The alkyloxy group having 1 to 6 carbon atoms or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.29 to R.sup.40, can be exemplified by the same ones as those shown in connection with the alkyloxy group having 1 to 6 carbon atoms, or the cycloalkyloxy group having 5 to 10 carbon atoms, represented by R.sup.23 to R.sup.28 in the general formula (6). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown in connection with the substituents for the alkyl group having 1 to 6 carbon atoms, the cycloalkyl group having 5 to 10 carbon atoms, or the alkenyl group having 2 to 6 carbon atoms, represented by R.sup.23 to R.sup.28 in the general formula (6). The same holds true of the embodiments that the substituents can adopt.

[0339] The aromatic hydrocarbon group, aromatic heterocyclic group, or condensed polycyclic aromatic group, represented by R.sup.29 to R.sup.40, can be exemplified by the same ones as those shown in connection with the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1). These groups may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 i.sup.n the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0340] The aryloxy group represented by R.sup.29 to R.sup.40 can be exemplified by the same ones as those shown in connection with the aryloxy group represented by R.sup.23 to R.sup.28 in the general formula (6). The aryloxy group represented by R.sup.29 to R.sup.40 may be unsubstituted, but may have a substituent. The substituent can be exemplified by the same ones as those shown as the substituents that the aromatic hydrocarbon group, the aromatic heterocyclic group, or the condensed polycyclic aromatic group represented by Ar.sup.1 to Ar.sup.4 in the general formula (1) may have. The same holds true of the embodiments that the substituents can adopt.

[0341] As R.sup.29 to R.sup.40, a deuterium atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aromatic hydrocarbon group, or a condensed polycyclic aromatic group is preferred; and a deuterium atom, a phenyl group, a biphenylyl group, a naphthyl group, or a vinyl group is more preferred. R.sup.29 to R.sup.40 may be present independently of each other to avoid the formation of a ring. However, it is preferred for R.sup.29 to R.sup.40 to bind to each other via a single bond, thereby forming a condensed aromatic ring. Particularly, a deuterium atom, a phenyl group, or a biphenylyl group is preferred.

(L.sup.2 to L.sup.4)

[0342] In the general formula (7), L.sup.2 to L.sup.4 are each a bridging group connecting the two triarylamine skeletons, and each represent a single bond, or a divalent group represented by the following structural formula (B′) or each of the aforementioned structural formulas (C) to (G). The divalent group represented by the following structural formula (B′) may be unsubstituted, or may be substituted by deuterium, as in the exemplary compound 7-17 in FIG. 64.

##STR00020##

[0343] where n2 denotes an integer of 1 to 3.

[0344] As L.sup.2 to L.sup.4, the divalent group represented by the structural formula (B′) or (D), or a single bond, is preferred; and the divalent group represented by the structural formula (B′), or a single bond, is more preferred. In the structural formula (B′), n2 is preferably 1 or 2, and more preferably 1.

[0345] Concrete examples of the preferred compounds among the triarylamine compounds of the general formula (6) are shown in FIGS. 55 to 59, but the triarylamine compounds of the general formula (6) are not limited to these exemplary compounds. In connection with the triarylamine compounds having two triarylamine structures among the aforementioned triarylamine compounds having two to six triarylamine structures, preferred examples of the compounds other than the triarylamine compounds of the general formula (6) are shown in FIG. 60. However, the triarylamine compounds having two triarylamine structures are not limited to these exemplary compounds. D in the structural formulas represents deuterium.

[0346] Concrete examples of the preferred compounds among the arylamine compounds of the general formula (7) are shown in FIGS. 61 to 64, but the triarylamine compounds of the general formula (7) are not limited to these exemplary compounds. D in the structural formulas represents deuterium.

[0347] The triarylamine compounds having 2 to 6 triarylamine structures, such as the triarylamine compounds of the general formula (6) or the triarylamine compounds of the general formula (7), can be synthesized in accordance with publicly known methods (see Patent Documents 1, 8 to 9).

Examples

[0348] The embodiments of the present invention will now be described specifically by the following Examples, which in no way limit the present invention.

Synthesis Example 1: Compound 1-5

[0349] Synthesis of 4-{(biphenyl-4-yl)-phenylamino}-4″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:3′,1″-terphenyl:

TABLE-US-00001 A nitrogen-purged reaction vessel was charged with 8.0 g, N-(biphenyl-4-yl)-N-(4-bromophenyl)aniline N-(9,9-dimethyl-9H-fluoren-2-yl)-N-{3′-(4,4,5,5- 11.4 g, tetramethyl-[1,3,2]dioxaboran-2-yl)biphenyl- 4-yl}aniline potassium carbonate 7.5 g, water 64 ml, toluene 64 ml, ethanol 16 ml, and tetrakis(triphenylphosphine)palladium 0.8 g.
The charge was heated, and stirred for 16 hours at 70° C. to prepare a mixture. The mixture was cooled to room temperature, and ethyl acetate and water were added, whereafter an organic layer was collected by liquid separation. The organic layer was concentrated, and then subjected to recrystallization using a THF/acetone mixed solvent. As a result, 9.54 g (yield 69%) of 4-{(biphenyl-4-yl)-phenylamino}-4″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:3′,1″-terphenyl (Compound 1-5) was obtained as a white powder.

##STR00021##

[0350] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 44 hydrogens were detected:

[00001] $\begin{matrix} δ (ppm) = .Math. 7.86 .Math. (1 .Math. H) \\ .Math. 7.68 - 6.97 .Math. (37 .Math. H) \\ .Math. 1.41 .Math. (6 .Math. H) \end{matrix}$

Synthesis Example 2: Compound 1-6

[0351] Synthesis of 4-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-4″-{(naphthalen-1-yl)-phenylamino}-1,1′:3′,1″-terphenyl:

[0352] Reactions were performed under the same conditions as in Synthesis Example 1, except that [0353] N-(3′-bromobiphenyl-4-yl)-N-(naphthalen-1-yl)aniline was used instead of [0354] N-(biphenyl-4-yl)-N-(4-bromophenyl)aniline,
and [0355] 4-{N-(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-phenylboronic acid
was used instead of [0356] N-(9,9-dimethyl-9H-fluoren-2-yl)-N-{3′-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)biphenyl-4-yl}aniline.
As a result, 7.88 g (yield 62%) of 4-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-4″-{(naphthalen-1-yl)-phenylamino}-1,1′:3′,1″-terphenyl (Compound 1-6) was obtained as a light yellowish white powder.

##STR00022##

[0357] In connection with the resulting light yellowish white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 42 hydrogens were detected:

[00002] $\begin{matrix} δ (ppm) = .Math. 7.98 .Math. (1 .Math. H) \\ .Math. 7.92 .Math. (1 .Math. H) \\ .Math. 7.84 - 7.75 .Math. (2 .Math. H) \\ .Math. 7.70 - 6.94 .Math. (32 .Math. H) \\ .Math. 1.49 .Math. (6 .Math. H) \end{matrix}$

Synthesis Example 3: Compound 1-21

[0358] Synthesis of 3,3″-bis{(biphenyl-4-yl)-phenylamino}-1,1′:4′,1″-terphenyl:

TABLE-US-00002 A nitrogen-purged reaction vessel was charged with 6.20 g, 1,4-dibromobenzene N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl- 25.1 g, [1,3,2]dioxaboran-2-yl)phenyl}aniline potassium carbonate 10.8 g, water 39 ml, toluene 380 ml, and ethanol 95 ml.
With the charge being ultrasonically irradiated for 30 minutes, a nitrogen gas was passed therethrough to prepare a mixture. To the mixture, tetrakis(triphenylphosphine)palladium (0.95 g) was added, and the system was heated and refluxed for 18 hours with stirring. Then, the mixture was cooled to room temperature, 200 ml of water and 190 ml of heptane were added, whereafter the resulting precipitate was collected by filtration. The precipitate was dissolved with heating in 1,200 ml of 1,2-dichlorobenzene, and the solution was subjected to adsorption purification using 39 g of silica gel, and then to adsorption purification using 19 g of activated clay. Then, 725 ml of methanol was added, and a crude product precipitated was collected by filtration. For the crude product, crystallization using a 1,2-dichloromethane/methanol mixed solvent was repeated, and then reflux washing using 300 ml of methanol was performed. As a result, 15.22 g (yield 81%) of 3,3″-bis{(biphenyl-4-yl)-phenylamino}-1,1′:4′,1″-terphenyl (Compound 1-21) was obtained as a white powder.

##STR00023##

[0359] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 40 hydrogens were detected:

[00003] $\begin{matrix} δ (ppm) = .Math. 7.61 .Math. (2 .Math. H) \\ .Math. 7.56 - 6.83 .Math. (38 .Math. H) \end{matrix}$

Synthesis Example 4: Compound 1-22

[0360] Synthesis of 2,2″-bis{(biphenyl-4-yl)-phenylamino}-1,1′:4′,1″-terphenyl:

[0361] Reactions were performed under the same conditions as in Synthesis Example 3, except that [0362] N-(biphenyl-4-yl)-N-{2-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline
was used instead of [0363] N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline.
As a result, 11.11 g (yield 58%) of 2,2″-bis{(biphenyl-4-yl)-phenylamino}-1,1′:4′,1″-terphenyl (Compound 1-22) was obtained as a white powder.

##STR00024##

[0364] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 40 hydrogens were detected:

[00004] $\begin{matrix} δ (ppm) = .Math. 7.52 .Math. (4 .Math. H) \\ .Math. 7.40 - 7.20 .Math. (18 .Math. H) \\ .Math. 7.03 .Math. (8 .Math. H) \\ .Math. 6.90 - 6.75 .Math. (10 .Math. H) \end{matrix}$

Synthesis Example 5: Compound 1-32

[0365] Synthesis of 4-{(biphenyl-4-yl)-phenylamino}-2″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:4′,1″-terphenyl:

TABLE-US-00003 A nitrogen-purged reaction vessel was charged with 10.0 g, N-(biphenyl-4-yl)-N-(2″-bromo-1,1′:4′,1″-terphenyl- 4-yl)aniline 2-(phenylamino)-9,9-dimethyl-9H-fluorene 6.2 g, palladium acetate 0.081 g, t-butoxysodium 3.5 g, a 50% (w/v) toluene solution of tri-t-butylphosphine 0.146 g, and toluene 100 ml.
The charge was heated, and stirred overnight at 100° C. to prepare a mixture. Insolubles were removed from the mixture by filtration, and the filtrate was concentrated. Then, the concentrate was purified using a column chromatograph (carrier: silica gel, eluent: heptane/dichloromethane). As a result, 4.77 g (yield 35%) of 4-{(biphenyl-4-yl)-phenylamino}-2″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:4′,1″-terphenyl (Compound 1-32) was obtained as a white powder.

##STR00025##

[0366] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 44 hydrogens were detected:

[00005] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.61 - 7.48 .Math. .Math. (4 .Math. .Math. H) \\ .Math. 7.42 - 6.92 .Math. .Math. (32 .Math. .Math. H) \\ .Math. 6.81 .Math. .Math. (1 .Math. .Math. H) \\ .Math. 6.76 .Math. .Math. (1 .Math. H) \\ .Math. 1.28 .Math. .Math. (6 .Math. H) \end{matrix}$

Synthesis Example 6: Compound 1-34

[0367] Synthesis of 4,4″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:3′,1″-terphenyl:

TABLE-US-00004 A nitrogen-purged reaction vessel was charged with 8.81 g, 4,4″-dibromo-1,1′:3′,1″-terphenyl 2-(phenylamino)-9,9-dimethyl-9H-fluorene 13.6 g, t-butoxysodium 5.12 g, tris(dibenzylideneacetone)dipalladium 0.33 g, and a 50% (w/v) toluene solution of tri-t-butylphosphine 0.63 ml.
The charge was heated and refluxed for 2 hours with stirring to prepare a mixture. The mixture was gradually cooled, then methanol was added, and the resulting precipitate was collected by filtration. The precipitate was dissolved with heating in chlorobenzene, and the solution was subjected to adsorption purification using silica gel. Then, adsorption purification using activated clay was performed, whereafter crystallization using a chlorobenzene/methanol mixed solvent was carried out. Then, reflux washing using methanol was performed. As a result, 16.25 g (yield 90%) of 4,4″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:3′,1″-terphenyl (Compound 1-34) was obtained as a white powder.

##STR00026##

[0368] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00006] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.84 .Math. .Math. (1 .Math. H) \\ .Math. 7.70 - 7.03 .Math. .Math. (35 .Math. H) \\ .Math. 1.48 .Math. .Math. (12 .Math. H) \end{matrix}$

Synthesis Example 7: Compound 1-37

[0369] Synthesis of 2-{(biphenyl-4-yl)-phenylamino}-4″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:4′,1″-terphenyl:

[0370] Reactions were performed under the same conditions as in Synthesis Example 5, except that [0371] N-(9,9-dimethyl-9H-fluoren-2-yl)-N-(2″-bromo-1,1′:4′,1″-terphenyl-4-yl)aniline
was used instead of [0372] N-(biphenyl-4-yl)-N-(2″-bromo-1,1′:4′,1″-terphenyl-4-yl)aniline,
and [0373] N-(biphenyl-4-yl)aniline
was used instead of [0374] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.

[0375] As a result, 11.7 g (yield 73%) of 2-{(biphenyl-4-yl)-phenylamino}-4″-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:4′,1″-terphenyl (Compound 1-37) was obtained as a white powder.

##STR00027##

[0376] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 44 hydrogens were detected:

[00007] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.68 .Math. .Math. (1 .Math. H) \\ .Math. 7.64 - 6.84 .Math. .Math. (37 .Math. H) \\ .Math. 1.48 .Math. .Math. (6 .Math. H) \end{matrix}$

Synthesis Example 8: Compound 1-38

[0377] Synthesis of 4,4″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:2′,1″-terphenyl:

[0378] Reactions were performed under the same conditions as in Synthesis Example 3, except that [0379] 1,2-diiodobenzene
was used instead of [0380] 1,4-dibromobenzene
and [0381] 4-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-phenylboronic acid
was used instead of [0382] N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline.
As a result, 6.6 g (yield 39%) of 4,4″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′:2′,1″-terphenyl (Compound 1-38) was obtained as a white powder.

##STR00028##

[0383] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00008] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.64 .Math. .Math. (2 .Math. H) \\ .Math. 7.58 .Math. .Math. (2 .Math. H) \\ .Math. 7.45 - 6.99 .Math. .Math. (32 .Math. H) \\ .Math. 1.38 .Math. .Math. (12 .Math. H) \end{matrix}$

Synthesis Example 9: Compound 1-39

[0384] Synthesis of 4,4″-bis{bis(biphenyl-4-yl)amino}-1,1′:2′,1″-terphenyl:

[0385] Reactions were performed under the same conditions as in Synthesis Example 3, except that [0386] 1,2-diiodobenzene
was used instead of [0387] 1,4-dibromobenzene
and [0388] 4-{bis(biphenyl-4-yl)amino}-phenylboronic acid
was used instead of [0389] N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline.
As a result, 4.6 g (yield 24%) of 4,4″-bis{bis(biphenyl-4-yl)amino}-1,1′: 2′,1″-terphenyl (Compound 1-39) was obtained as a white powder.

##STR00029##

[0390] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00009] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.57 - 7.28 .Math. .Math. (32 .Math. H) \\ .Math. 7.21 .Math. .Math. (8 .Math. H) \\ .Math. 7.11 .Math. .Math. (8 .Math. H) \end{matrix}$

Synthesis Example 10: Compound 1-41

[0391] Synthesis of 4,4″-bis{(biphenyl-4-yl)-(naphthalen-1-yl)amino}-1,1′: 2′,1″-terphenyl:

[0392] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0393] 4,4″-dibromo-1,1′: 2′,1l″-terphenyl
was used instead of [0394] 4,4″-dibromo-1,1′: 3′,1″-terphenyl
and [0395] (biphenyl-4-yl)-(naphthalen-1-yl)amine
was used instead of [0396] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.
As a result, 5.0 g (yield 30%) of 4,4″-bis{(biphenyl-4-yl)-(naphthalen-1-yl)amino}-1,1′: 2′,1″-terphenyl (Compound 1-41) was obtained as a white powder.

##STR00030##

[0397] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 44 hydrogens were detected:

[00010] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.93 - 7.84 .Math. .Math. (4 .Math. H) \\ .Math. 7.79 .Math. .Math. (2 .Math. H) \\ .Math. 7.60 - 7.26 .Math. .Math. (24 .Math. H) \\ .Math. 7.25 - 6.92 .Math. .Math. (14 .Math. H) \end{matrix}$

Synthesis Example 11: Compound 1-42

[0398] Synthesis of 4,4″-bis[{4-(naphthalen-1-yl)phenyl}-phenylamino]-1,1′: 2′,1″-terphenyl:

[0399] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0400] 4,4″-dibromo-1,1′: 2′,1″-terphenyl
was used instead of [0401] 4,4″-dibromo-1,1′: 3′,1″-terphenyl
and [0402] N-{4-(naphthalen-1-yl)phenyl}aniline
was used instead of [0403] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.
As a result, 7.3 g (yield 43%) of 4,4″-bis[{4-(naphthalen-1-yl)phenyl}-phenylamino]-1,1′: 2′,1″-terphenyl (Compound 1-42) was obtained as a white powder.

##STR00031##

[0404] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 44 hydrogens were detected:

[00011] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 8.01 .Math. .Math. (2 .Math. H) \\ .Math. 7.91 .Math. .Math. (2 .Math. H) \\ .Math. 7.84 .Math. .Math. (2 .Math. H) \\ .Math. 7.53 - 6.98 .Math. .Math. (38 .Math. H) \end{matrix}$

Synthesis Example 12: Compound 1-45

[0405] Synthesis of 4,4″-bis[{4-(naphthalen-1-yl)phenyl}-phenylamino]-1,1′: 3′,1″-terphenyl:

[0406] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0407] N-{4-(naphthalen-1-yl)phenyl}aniline
was used instead of [0408] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.
As a result, 16.7 g (yield 79%) of 4,4″-bis[{4-(naphthalen-1-yl)phenyl}-phenylamino]-1,1′: 3′,1″-terphenyl (Compound 1-45) was obtained as a white powder.

##STR00032##

[0409] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 44 hydrogens were detected:

[00012] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 8.08 .Math. .Math. (2 .Math. H) \\ .Math. 7.94 .Math. .Math. (2 .Math. H) \\ .Math. 7.90 - 7.80 .Math. .Math. (3 .Math. H) \\ .Math. 7.65 - 7.00 .Math. .Math. (37 .Math. H) \end{matrix}$

Synthesis Example 13: Compound 1-47

[0410] Synthesis of 2,2″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′: 3′,1″-terphenyl:

[0411] Reactions were performed under the same conditions as in Synthesis Example 3, except that [0412] 1,3-diiodobenzene
was used instead of [0413] 1,4-dibromobenzene,
and [0414] 2-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-phenylboronic acid
was used instead of [0415] N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline.
As a result, 4.2 g (yield 25%) of 2,2″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′: 3′,1″-terphenyl (Compound 1-47) was obtained as a white powder.

##STR00033##

[0416] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00013] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.60 .Math. .Math. (2 .Math. H) \\ .Math. 7.38 - 7.09 .Math. .Math. (14 .Math. H) \\ .Math. 6.95 - 6.71 .Math. .Math. (14 .Math. H) \\ .Math. 6.66 - 6.56 .Math. .Math. (4 .Math. H) \\ .Math. 6.35 .Math. .Math. (2 .Math. H) \\ .Math. 1.26 .Math. .Math. (12 .Math. H) \end{matrix}$

Synthesis Example 14: Compound 1-49

[0417] Synthesis of 2,2″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′: 4′,1″-terphenyl:

[0418] Reactions were performed under the same conditions as in Synthesis Example 3, except that [0419] 2-{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-phenylboronic acid
was used instead of [0420] N-(biphenyl-4-yl)-N-{3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)phenyl}aniline.
As a result, 13.7 g (yield 76%) of 2,2″-bis{(9,9-dimethyl-9H-fluoren-2-yl)-phenylamino}-1,1′: 4′,1″-terphenyl (Compound 1-49) was obtained as a white powder.

##STR00034##

[0421] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 48 hydrogens were detected:

[00014] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.53 .Math. .Math. (2 .Math. H) \\ .Math. 7.35 - 6.81 .Math. .Math. (30 .Math. H) \\ .Math. 6.76 .Math. .Math. (2 .Math. H) \\ .Math. 6.67 .Math. .Math. (2 .Math. H) \\ .Math. 1.29 .Math. .Math. (12 .Math. H) \end{matrix}$

Synthesis Example 15: Compound 1-88

[0422] Synthesis of 4,4″-bis{(triphenylen-2-yl) phenylamino}-1,1′: 4′,1″-terphenyl:

[0423] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0424] 4,4″-diiodo-1,1′: 4′,1″-terphenyl
was used instead of [0425] 4,4″-dibromo-1,1′: 3′,1″-terphenyl
and [0426] N-(triphenylen-2-yl)aniline
was used instead of [0427] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.

[0428] As a result, 11.4 g (yield 74%) of 4,4″-bis{(triphenylen-2-yl)-phenylamino}-1,1′: 4′,1″-terphenyl (Compound 1-88) was obtained as a white powder.

##STR00035##

[0429] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 44 hydrogens were detected:

[00015] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 8.72 - 8.62 .Math. .Math. (8 .Math. H) \\ .Math. 8.45 .Math. .Math. (2 .Math. H) \\ .Math. 8.36 .Math. .Math. (2 .Math. H) \\ .Math. 7.75 .Math. .Math. (4 .Math. H) \\ .Math. 7.70 - 7.21 .Math. .Math. (26 .Math. H) \\ .Math. 7.09 .Math. .Math. (2 .Math. H) \end{matrix}$

Synthesis Example 16: Compound 1-91

[0430] Synthesis of 4-{(biphenyl-4-yl)-phenylamino}-4″-[{4-(1-phenyl-indol-4-yl)phenyl}-phenylamino]-1,1′: 4′,1″-terphenyl:

[0431] Reactions were performed under the same conditions as in Synthesis Example 1, except that [0432] N-(4′-bromo-1,1′-biphenyl-4-yl)-{4-(1-phenyl-indol-4-yl)phenyl}aniline
was used instead of [0433] N-(biphenyl-4-yl)-N-(4-bromophenyl)aniline,
and [0434] N-{4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl}-(1,1′-biphenyl-4-yl)aniline
was used instead of [0435] N-(9,9-dimethyl-9H-fluoren-2-yl)-N-{3′-(4,4,5,5-tetramethyl-[1,3,2]dioxaboran-2-yl)biphenyl-4-yl}aniline.
As a result, 6.80 g (yield 67%) of 4-{(biphenyl-4-yl)-phenylamino}-4″-[{4-(1-phenyl-indol-4-yl)phenyl}-phenylamino]-1,1′: 4′,1″-terphenyl (Compound 1-91) was obtained as a light yellow powder.

##STR00036##

[0436] In connection with the resulting light yellow powder, its structure was identified using NMR. In .sup.1H-NMR (THF-d.sub.8), the following signals of 45 hydrogens were detected:

[00016] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.70 .Math. .Math. (4 .Math. H) \\ .Math. 7.68 - 7.50 .Math. .Math. (16 .Math. H) \\ .Math. 7.42 - 7.11 .Math. .Math. (23 .Math. H) \\ .Math. 7.05 .Math. .Math. (1 .Math. H) \\ .Math. 6.88 .Math. .Math. (1 .Math. H) \end{matrix}$

Synthesis Example 17: Compound 1-101

[0437] Synthesis of 4,4″-bis{N-phenyl-N-(2-phenybiphenyl-4-yl)amino}-1,1′: 4′,1″-terphenyl:

TABLE-US-00005 A nitrogen-purged reaction vessel was charged with 13.0 g, 4,4″-diiodo-1,1′:4′,1″-terphenyl N-(2-phenylbiphenyl-4-yl)aniline 20.0 g, copper powder 0.18 g, potassium carbonate 11.3 g, 3,5-di-tert-butylsalicylic acid 0.7 g, sodium bisulfite 0.86 g, and dodecylbenzene 30 ml.
The charge was heated, and stirred for 24 hours at 210° C. to prepare a mixture. The mixture was cooled, and then 30 ml of xylene and 60 ml of methanol were added, whereafter the resulting precipitate was collected by filtration. To the precipitate, 250 ml of toluene and 20 g of silica were added, and the mixture was heated to 90° C. to prepare a precipitate solution. Then, insolubles were removed from the precipitate solution by hot filtration, and then the precipitate solution was concentrated. Then, ethyl acetate and methanol were added to the precipitate concentrate to precipitate a crude product, which was collected by filtration. Recrystallization of the crude product was performed using chlorobenzene, and then a reflux washing operation was performed using methanol. As a result, 16.9 g (yield 72%) of 4,4″-bis{N-phenyl-N-(2-phenybiphenyl-4-yl)amino}-1,1′: 4′,1″-terphenyl (Compound 1-101) was obtained as a white powder.

##STR00037##

[0438] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00017] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.68 .Math. .Math. (4 .Math. H) \\ .Math. 7.62 - 7.55 .Math. .Math. (4 .Math. H) \\ .Math. 7.39 - 7.06 .Math. .Math. (40 .Math. H) \end{matrix}$

Synthesis Example 18: Compound 1-103

[0439] Synthesis of 4,4″-bis{(2-phenylbiphenyl-4-yl)-phenylamino}-1,1′: 2′,1″-terphenyl:

[0440] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0441] 4,4″-dibromo-1,1′: 2′,1″-terphenyl
was used instead of [0442] 4,4″-dibromo-1,1′: 3′,1″-terphenyl
and [0443] N-(2-phenylbiphenyl-4-yl)aniline
was used instead of [0444] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.
As a result, 4.3 g (yield 42%) of 4,4″-bis{(2-phenylbiphenyl-4-yl)-phenylamino}-1,1′: 2′,1″-terphenyl (Compound 1-103) was obtained as a white powder.

##STR00038##

[0445] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00018] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.50 - 7.39 .Math. .Math. (4 .Math. H) \\ .Math. 7.31 - 6.97 .Math. .Math. (44 .Math. H) \end{matrix}$

Synthesis Example 19: Compound 1-104

[0446] Synthesis of 4,4″-bis{(2-phenylbiphenyl-4-yl)-phenylamino}-1,1′: 3′,1″-terphenyl:

[0447] Reactions were performed under the same conditions as in Synthesis Example 6, except that [0448] N-(2-phenylbiphenyl-4-yl)aniline
was used instead of [0449] 2-(phenylamino)-9,9-dimethyl-9H-fluorene.
As a result, 7.7 g (yield 53%) of 4,4″-bis{(2-phenylbiphenyl-4-yl)-phenylamino}-1,1′: 3′,1″-terphenyl (Compound 1-104) was obtained as a white powder.

##STR00039##

[0450] In connection with the resulting white powder, its structure was identified using NMR. In .sup.1H-NMR (CDCl.sub.3), the following signals of 48 hydrogens were detected:

[00019] $\begin{matrix} δ .Math. .Math. (ppm) = .Math. 7.81 .Math. .Math. (2 .Math. H) \\ .Math. 7.61 - 7.48 .Math. .Math. (14 .Math. H) \\ .Math. 7.39 - 7.06 .Math. .Math. (32 .Math. H) \end{matrix}$

[0451] The various compounds obtained in the Synthesis Examples were measured for the glass transition temperature by a high-sensitivity differential scanning calorimeter (DSC3100SA, produced by Bruker AXS K.K.).

TABLE-US-00006 Glass transition temperature Compound of Synthesis Example 1 (Compound 1-5) 117° C. Compound of Synthesis Example 2 (Compound 1-6) 117° C. Compound of Synthesis Example 3 (Compound 1-21) 103° C. Compound of Synthesis Example 5 (Compound 1-32) 115° C. Compound of Synthesis Example 6 (Compound 1-34) 124° C. Compound of Synthesis Example 7 (Compound 1-37) 114° C. Compound of Synthesis Example 8 (Compound 1-38) 119° C. Compound of Synthesis Example 9 (Compound 1-39) 106° C. Compound of Synthesis Example 10 (Compound 1-41) 127° C. Compound of Synthesis Example 11 (Compound 1-42) 111° C. Compound of Synthesis Example 12 (Compound 1-45) 122° C. Compound of Synthesis Example 13 (Compound 1-47) 116° C. Compound of Synthesis Example 14 (Compound 1-49) 117° C. Compound of Synthesis Example 15 (Compound 1-88) 163° C. Compound of Synthesis Example 16 (Compound 1-91) 125° C. Compound of Synthesis Example 17 (Compound 1-101) 124° C. Compound of Synthesis Example 18 (Compound 1-103) 115° C. Compound of Synthesis Example 19 (Compound 1-104) 122° C.

[0452] The above results show that the arylamine compounds represented by the general formula (1) have a glass transition temperature of 100° C. or higher, demonstrating that they are stable in a thin film state.

[0453] Using each of the arylamine compounds obtained in the Synthesis Examples, a vapor deposited film with a film thickness of 100 nm was prepared on an ITO substrate, and its work function was measured using an ionization potential measuring device (PYS-202, produced by Sumitomo Heavy Industries, Ltd.).

TABLE-US-00007 Work function Compound of Synthesis Example 1 (Compound 1-5) 5.68 eV Compound of Synthesis Example 2 (Compound 1-6) 5.65 eV Compound of Synthesis Example 3 (Compound 1-21) 5.79 eV Compound of Synthesis Example 4 (Compound 1-22) 5.83 eV Compound of Synthesis Example 5 (Compound 1-32) 5.69 eV Compound of Synthesis Example 6 (Compound 1-34) 5.65 eV Compound of Synthesis Example 7 (Compound 1-37) 5.67 eV Compound of Synthesis Example 8 (Compound 1-38) 5.64 eV Compound of Synthesis Example 9 (Compound 1-39) 5.66 eV Compound of Synthesis Example 10 (Compound 1-41) 5.69 eV Compound of Synthesis Example 11 (Compound 1-42) 5.75 eV Compound of Synthesis Example 12 (Compound 1-45) 5.76 eV Compound of Synthesis Example 13 (Compound 1-47) 5.72 eV Compound of Synthesis Example 14 (Compound 1-49) 5.72 eV Compound of Synthesis Example 15 (Compound 1-88) 5.62 eV Compound of Synthesis Example 16 (Compound 1-91) 5.67 eV Compound of Synthesis Example 17 (Compound 1-101) 5.67 eV Compound of Synthesis Example 18 (Compound 1-103) 5.75 eV Compound of Synthesis Example 19 (Compound 1-104) 5.76 eV

[0454] The arylamine compounds represented by the general formula (1) were found to show a suitable energy level as compared with a work function of 5.4 eV which an ordinary hole transport material such as NPD or TPD has. Thus, these compounds are found to have satisfactory hole transport capability.

Synthesis Example 20: Compound 2-1

[0455] Synthesis of 7,7-dimethyl-12-(4-phenylquinazolin-2-yl)-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole:

TABLE-US-00008 A nitrogen-purged reaction vessel was charged with 4.9 g, 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2- g]indeno[1,2-b]indole 2-chloro-4-phenylquinazoline 5.7 g, tris(dibenzylideneacetone)dipalladium 0.3 g, tri-tert-butylphosphonium tetrafluoroborate 0.4 g, tert-butoxysodium 4.0 g, and xylene 74 ml.
The charge was heated, and stirred for 12 hours under reflux to prepare a mixture. The mixture was cooled to room temperature, and ethyl acetate and water were added, whereafter an organic layer was collected by liquid separation. The organic layer was concentrated, and then purified using a column chromatograph. As a result, 3.0 g (yield 38%) of 7,7-dimethyl-12-(4-phenylquinazolin-2-yl)-7,12-dihydrobenzo [4,5]thieno[3,2-g]indeno [1,2-b]indole (Compound 2-1) was obtained as a powder.

##STR00040##

Synthesis Example 21: Compound 2-2>

[0456] Synthesis of 7,7-dimethyl-12-(4-phenylbenzo[h]quinazolin-2-yl)-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole:

[0457] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0458] 2-chloro-4-phenylbenzo[h]quinazoline
was used instead of [0459] 2-chloro-4-phenylquinazoline.
As a result, 3.2 g (yield 38%) of 7,7-dimethyl-12-(4-phenylbenzo[h]quinazolin-2-yl)-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole (Compound 2-2) was obtained as a powder.

##STR00041##

Synthesis Example 22: Compound 2-3>

[0460] Synthesis of 12-(4,7-diphenylquinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole:

[0461] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0462] 2-chloro-4,7-diphenylquinazoline
was used instead of [0463] 2-chloro-4-phenylquinazoline.
As a result, 3.3 g (yield 38%) of 12-(4,7-diphenylquinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzo [4,5]thieno[3,2-g]indeno [1,2-b]indole (Compound 2-3) was obtained as a powder.

##STR00042##

Synthesis Example 23: Compound 2-4>

[0464] Synthesis of 12-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole:

[0465] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0466] 2-chloro-4,6-diphenylquinazoline
was used instead of [0467] 2-chloro-4-phenylquinazoline.
As a result, 3.3 g (yield 38%) of 12-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzo [4,5]thieno [3,2-g]indeno [1,2-b]indole (Compound 2-4) was obtained as a powder.

##STR00043##

Synthesis Example 24: Compound 2-5>

[0468] Synthesis of 13,13-dimethyl-8-(4-phenylquinazolin-2-yl)-8,13-dihydrobenzo[4,5]thieno [3,2-e]indeno [1, 2-b]indole:

[0469] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0470] 13,13-dimethyl-8,13-dihydrobenzo[4,5]thieno[3,2-e]indeno [1,2-b]indole
was used instead of [0471] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 3.0 g (yield 38%) of 13,13-dimethyl-8-(4-phenylquinazolin-2-yl)-8,13-dihydrobenzo[4,5]thieno[3,2-e]indeno[1,2-b]indole (Compound 2-5) was obtained as a powder.

##STR00044##

Synthesis Example 25: Compound 2-6>

[0472] Synthesis of 8-(4,6-diphenylquinazolin-2-yl)-13,13-dimethyl-8,13-dihydrobenzo[4,5]thieno[3,2-e]indeno[1,2-b]indole:

[0473] Reactions were performed under the same conditions as in Synthesis Example 24, except that [0474] 2-chloro-4,6-diphenylquinazoline
was used instead of [0475] 2-chloro-4-phenylquinazoline.
As a result, 3.3 g (yield 38%) of 8-(4,6-diphenylquinazolin-2-yl)-13,13-dimethyl-8,13-dihydrobenzo[4,5]thieno[3,2-e]indeno[1,2-b]indole (Compound 2-6) was obtained as a powder.

##STR00045##

Synthesis Example 26: Compound 2-7>

[0476] Synthesis of 7,7,13,13-tetramethyl-5-(4-phenylquinazolin-2-yl)-7,13-dihydro-5H-diindeno[1,2-b:1′,2′-f]indole:

[0477] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0478] 7,7,13,13-tetramethyl-7,13-dihydro-5H-diindeno[1,2-b:1′,2′-f]indole
was used instead of [0479] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno[1,2-b]indole.
As a result, 3.0 g (yield 38%) of 7,7,13,13-tetramethyl-5-(4-phenylquinazolin-2-yl)-7,13-dihydro-5H-diindeno[1,2-b:1′,2′-f]indole (Compound 2-7) was obtained as a powder.

##STR00046##

Synthesis Example 27: Compound 2-8

[0480] Synthesis of 7,7,13,13-tetramethyl-5-[3-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydro-5H-diindeno[1,2-b:1′,2′-f]indole:

[0481] Reactions were performed under the same conditions as in Synthesis Example 26, except that [0482] 2-(3-bromophenyl)-4-phenylquinazoline
was used instead of [0483] 2-chloro-4-phenylquinazoline.
As a result, 3.4 g (yield 38%) of 7,7,13,13-tetramethyl-5-[3-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydro-5H-diindeno[1,2-b:1′,2′-f]indole (Compound 2-8) was obtained as a powder.

##STR00047##

Synthesis Example 28: Compound 2-9>

[0484] Synthesis of 7,7-dimethyl-12-(4-phenylbenzo[h]quinazolin-2-yl)-7,12-dihydrobenzofuro [3,2-g]indeno [1,2-b]indole:

[0485] Reactions were performed under the same conditions as in Synthesis Example 21, except that [0486] 7,7-dimethyl-7,12-dihydrobenzofuro[3,2-g]indeno [1,2-b]indole
was used instead of [0487] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 3.0 g (yield 38%) of 7,7-dimethyl-12-(4-phenylbenzo[h]quinazolin-2-yl)-7,12-dihydrobenzofuro [3,2-g]indeno [1,2-b]indole (Compound 2-9) was obtained as a powder.

##STR00048##

Synthesis Example 29: Compound 2-10>

[0488] Synthesis of 12-(4,6-diphenylbenzo[h]quinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzofuro [3,2-g]indeno [1,2-b]indole:

[0489] Reactions were performed under the same conditions as in Synthesis Example 28, except that [0490] 2-chloro-4,6-diphenylbenzo [h]quinazoline
was used instead of [0491] 2-chloro-4-phenylbenzo[h]quinazoline.
As a result, 3.5 g (yield 38%) of 12-(4,6-diphenylbenzo[h]quinazolin-2-yl)-7,7-dimethyl-7,12-dihydrobenzofuro[3,2-g]indeno[1,2-b]indole (Compound 2-10) was obtained as a powder.

##STR00049##

Synthesis Example 30: Compound 2-11>

[0492] Synthesis of 13,13-dimethyl-8-(4-phenylquinazolin-2-yl)-8,13-dihydrobenzofuro [3,2-e]indeno [1,2-b]indole:

[0493] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0494] 13,13-dimethyl-8,13-dihydrobenzofuro[3,2-e]indeno [1,2-b]indole
was used instead of [0495] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 3.0 g (yield 38%) of 13,13-dimethyl-8-(4-phenylquinazolin-2-yl)-8,13-dihydrobenzofuro[3,2-e]indeno[1,2-b]indole (Compound 2-11) was obtained as a powder.

##STR00050##

Synthesis Example 31: Compound 2-12

[0496] Synthesis of 13,13-dimethyl-8-(4,6-diphenylquinazolin-2-yl)-8,13-dihydrobenzofuro [3,2-e]indeno [1, 2-b]indole:

[0497] Reactions were performed under the same conditions as in Synthesis Example 30, except that [0498] 2-chloro-4,6-diphenylquinazoline
was used instead of [0499] 2-chloro-4-phenylquinazoline.
As a result, 3.2 g (yield 38%) of 13,13-dimethyl-8-(4,6-diphenylquinazolin-2-yl)-8,13-dihydrobenzofuro [3,2-e]indeno [1,2-b]indole (Compound 2-12) was obtained as a powder.

##STR00051##

Synthesis Example 32: Compound 3-1>

[0500] Synthesis of 13-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0501] Reactions were performed under the same conditions as in Synthesis Example 31, except that [0502] 7,7-dimethyl-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole
was used instead of [0503] 13,13-dimethyl-8,13-dihydrobenzofuro[3,2-e]indeno [1,2-b]indole.
As a result, 7.0 g (yield 38%) of 13-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno [2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-1) was obtained as a powder.

##STR00052##

Synthesis Example 33: Compound 3-2>

[0504] Synthesis of 13-[4-(biphenyl-4-yl)quinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0505] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0506] 4-(biphenyl-4-yl)-2-chloroquinazoline
was used instead of [0507] 2-chloro-4,6-diphenylquinazoline.
As a result, 6.7 g (yield 37%) of 13-[4-(biphenyl-4-yl)quinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-2) was obtained as a powder.

##STR00053##

Synthesis Example 34: Compound 3-3>

[0508] Synthesis of 7,7-dimethyl-13-[4-(phenyl-d.sub.5) quinazolin-2-yl]-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0509] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0510] 2-chloro-4-(phenyl-d.sub.5) quinazoline
was used instead of [0511] 2-chloro-4,6-diphenylquinazoline.
As a result, 8.4 g (yield 32%) of 7,7-dimethyl-13-[4-(phenyl-d.sub.5) quinazolin-2-yl]-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-3) was obtained as a powder.

##STR00054##

Synthesis Example 35: Compound 3-4>

[0512] Synthesis of 7,7-dimethyl-13-[4-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0513] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0514] 2-(4-bromophenyl)-4-phenylquinazoline
was used instead of [0515] 2-chloro-4,6-diphenylquinazoline.
As a result, 5.2 g (yield 28%) of 7,7-dimethyl-13-[4-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-4) was obtained as a powder.

##STR00055##

Synthesis Example 36: Compound 3-5>

[0516] Synthesis of 7,7-dimethyl-13-[3-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0517] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0518] 2-(3-bromophenyl)-4-phenylquinazoline
was used instead of [0519] 2-chloro-4,6-diphenylquinazoline.
As a result, 8.4 g (yield 32%) of 7,7-dimethyl-13-[3-(4-phenylquinazolin-2-yl)phenyl]-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole (Compound 3-5) was obtained as a powder.

##STR00056##

Synthesis Example 37: Compound 3-6>

[0520] Synthesis of 7,7-dimethyl-13-(4-phenylbenzo[h]quinazolin-2-yl)-7,13-dihydroindeno [2′,1′: 4,5]thieno [2,3-a]carbazole:

[0521] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0522] 2-chloro-4-phenylbenzo [h]quinazoline
was used instead of [0523] 2-chloro-4,6-diphenylquinazoline.
As a result, 8.4 g (yield 32%) of 7,7-dimethyl-13-(4-phenylbenzo[h]quinazolin-2-yl)-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-6) was obtained as a powder.

##STR00057##

Synthesis Example 38: Compound 3-7>

[0524] Synthesis of 8,8-dimethyl-5-(4-phenylbenzo[h]quinazolin-2-yl)-5,8-dihydroindeno [2′,1′: 4,5]thieno [3,2-c]carbazole:

[0525] Reactions were performed under the same conditions as in Synthesis Example 37, except that [0526] 8,8-dimethyl-5,8-dihydroindeno[2′,1′: 4,5]thieno[3,2-c]carbazole
was used instead of [0527] 7,7-dimethyl-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole.
As a result, 9.3 g (yield 35%) of 8,8-dimethyl-5-(4-phenylbenzo[h]quinazolin-2-yl)-5,8-dihydroindeno [2′,1′: 4,5]thieno [3,2-c]carbazole (Compound 3-7) was obtained as a powder.

##STR00058##

Synthesis Example 39: Compound 3-8>

[0528] Synthesis of 7,7-dimethyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindeno [2′,1′: 4,5]furo [2,3-a]carbazole:

[0529] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0530] 7,7-dimethyl-7,13-dihydroindeno[2′,1′: 4,5]furo[2,3-a]carbazole
was used instead of [0531] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 6.2 g (yield 32%) of 7,7-dimethyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindeno[2′,1′: 4,5]furo[2,3-a]carbazole (Compound 3-8) was obtained as a powder.

##STR00059##

Synthesis Example 40: Compound 3-9>

[0532] Synthesis of 7,7-dimethyl-13-(4-phenylbenzo[h]quinazolin-2-yl)-7,13-dihydroindeno [2′,1′: 4,5]furo [2,3-a]carbazole:

[0533] Reactions were performed under the same conditions as in Synthesis Example 39, except that [0534] 2-chloro-4-phenylbenzo[h]quinazoline
was used instead of [0535] 2-chloro-4-phenylquinazoline.
As a result, 8.6 g (yield 30%) of 7,7-dimethyl-13-(4-phenylbenzo[h]quinazolin-2-yl)-7,13-dihydroindeno[2′,1′: 4,5]furo[2,3-a]carbazole (Compound 3-9) was obtained as a powder.

##STR00060##

Synthesis Example 41: Compound 3-10>

[0536] Synthesis of 13-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno[2′,1′: 4,5]furo[2,3-a]carbazole:

[0537] Reactions were performed under the same conditions as in Synthesis Example 39, except that [0538] 2-chloro-4,6-diphenylquinazoline
was used instead of [0539] 2-chloro-4-phenylquinazoline.
As a result, 7.2 g (yield 29%) of 13-(4,6-diphenylquinazolin-2-yl)-7,7-dimethyl-7,13-dihydroindeno [2′,1′: 4,5]furo [2,3-a]carbazole (Compound 3-10) was obtained as a powder.

##STR00061##

Synthesis Example 42: Compound 3-11>

[0540] Synthesis of 7,7-diphenyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindeno [2′,1′: 4,5]thieno[2,3-a]carbazole:

[0541] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0542] 7,7-diphenyl-7,13-dihydroindeno[2′,1′: 4,5]thieno[3,2-a]carbazole
was used instead of [0543] 7,7-dimethyl-7,12-dihydrobenzo [4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 6.7 g (yield 37%) of 7,7-diphenyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindeno [2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-11) was obtained as a powder.

##STR00062##

Synthesis Example 43: Compound 3-12>

[0544] Synthesis of 9,9-dimethyl-15-(4-phenylquinazolin-2-yl)-9,15-dihydrobenzo [a]indeno [2′,1′: 4,5]thieno[3,2-i]carbazole:

[0545] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0546] 9,9-dimethyl-9,15-dihydrobenzo [a]indeno [2′,1′: 4,5]thieno[3,2-i]carbazole
was used instead of [0547] 7,7-dimethyl-7,12-dihydrobenzo[4,5]thieno[3,2-g]indeno [1,2-b]indole.
As a result, 4.8 g (yield 42%) of 9,9-dimethyl-15-(4-phenylquinazolin-2-yl)-9,15-dihydrobenzo[a]indeno[2′,1′: 4,5]thieno[3,2-i]carbazole (Compound 3-12) was obtained as a powder.

##STR00063##

Synthesis Example 44: Compound 3-13>

[0548] Synthesis of 7-phenyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindolo[2′,3′: 4,5]thieno[2,3-a]carbazole:

[0549] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0550] 7-phenyl-7,13-dihydroindolo[2′,3′: 4,5]thieno[2,3-a]carbazole
was used instead of [0551] 7,7-dimethyl-7,12-dihydrobenzo [4,5]thieno [3,2-g]indeno [1,2-b]indole.
As a result, 4.3 g (yield 43%) of 7-phenyl-13-(4-phenylquinazolin-2-yl)-7,13-dihydroindolo [2′,3′: 4,5]thieno[2,3-a]carbazole (Compound 3-13) was obtained as a powder.

##STR00064##

Synthesis Example 45: Compound 3-14>

[0552] Synthesis of 12,12-dimethyl-1-(4-phenylquinazolin-2-yl)-1,12-dihydroindeno [1′,2′: 4,5]thieno [2,3-a]carbazole:

[0553] Reactions were performed under the same conditions as in Synthesis Example 20, except that [0554] 12,12-dimethyl-1,12-dihydroindeno [1′,2′: 4,5]thieno [2,3-a]carbazole
was used instead of [0555] 7,7-dimethyl-7,12-dihydrobenzo [4,5]thieno [3,2-g]indeno [1,2-b]indole.
As a result, 6.3 g (yield 44%) of 12,12-dimethyl-l-(4-phenylquinazolin-2-yl)-1,12-dihydroindeno[1′,2′: 4,5]thieno[2,3-a]carbazole (Compound 3-14) was obtained as a powder.

##STR00065##

Synthesis Example 46: Compound 3-15

[0556] Synthesis of 7,7-dimethyl-13-(naphthalen-2-yl)-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole:

[0557] Reactions were performed under the same conditions as in Synthesis Example 32, except that [0558] 2-bromonaphthalene
was used instead of [0559] 2-chloro-4,6-diphenylquinazoline.
As a result, 5.4 g (yield 47%) of 7,7-dimethyl-13-(naphthalen-2-yl)-7,13-dihydroindeno[2′,1′: 4,5]thieno[2,3-a]carbazole (Compound 3-15) was obtained as a powder.

##STR00066##

Example 1

[0560] As shown in FIG. 1, the hole injection layer 3, the first hole transport layer 5a, the second hole transport layer 5b, the luminous layer 6, the electron transport layer 7, the electron injection layer 8, and the cathode (aluminum electrode) 9 were vapor-deposited in this order on an ITO electrode formed beforehand as the transparent anode 2 on the glass substrate 1 to prepare the organic EL device.

[0561] Concretely, the glass substrate 1 having a 150 nm thick ITO film formed thereon was ultrasonically cleaned for 20 minutes in isopropyl alcohol, and then dried for 10 minutes on a hot plate heated to 200° C. Then, the glass substrate with ITO was subjected to UV/ozone treatment for 15 minutes. Then, the ITO-equipped glass substrate was attached inside a vacuum vapor deposition device, and the pressure was reduced to 0.001 Pa or lower.

[0562] Then, the hole injection layer 3 was formed. Concretely, HIM-1 represented by the following structural formula was vapor-deposited so as to cover the transparent anode 2, thereby forming the hole injection layer 3 in a film thickness of 5 nm.

##STR00067##

[0563] Then, the first hole transport layer 5a was formed. Concretely, a triarylamine compound 6-1 represented by the following structural formula was vapor-deposited on the hole injection layer 3 to form the first hole transport layer 5a with a film thickness of 60 nm.

##STR00068##

[0564] Then, the second hole transport layer 5b was formed. Concretely, Compound 1-5 of Synthesis Example 1 was vapor-deposited on the first hole transport layer 5a to form the second hole transport layer 5b with a film thickness of 5 nm.

##STR00069##

[0565] Then, the luminous layer 6 was formed. Concretely, a compound EMD-1 of the following structural formula and Compound 2-4 of Synthesis Example 23 were binary vapor deposited on the second hole transport layer 5b at such vapor deposition rates that the vapor deposition rate ratio was EMD-1:Compound 2−4=5:95, whereby the luminous layer 6 was formed in a film thickness of 20 nm.

##STR00070##

[0566] Then, the electron transport layer 7 was formed. Concretely, a pyrimidine derivative 4-123 of the following structural formula and a compound ETM-1 of the following structural formula were binary vapor deposited on the luminous layer 6 at such vapor deposition rates that the vapor deposition rate ratio was pyrimidine derivative 4-123:ETM-1=50:50, whereby the electron transport layer 7 was formed in a film thickness of 30 nm.

##STR00071##

[0567] Then, the electron injection layer 8 was formed. Concretely, lithium fluoride was vapor deposited on the electron transport layer 7 to form the electron injection layer 8 in a film thickness of 1 nm.

[0568] Finally, aluminum was vapor deposited to a film thickness of 100 nm to form the cathode 9.

[0569] The so prepared organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration of the resulting organic EL device is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 2

[0570] An organic EL device was prepared under the same conditions as in Example 1, except that Compound 1-34 of Synthesis Example 6 was used instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

##STR00072##

Example 3

[0571] An organic EL device was prepared under the same conditions as in Example 1, except that a pyrimidine derivative 4-125 of the following structural formula was used, instead of the pyrimidine derivative 4-123, as the material for the electron transport layer 7. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

##STR00073##

Example 4

[0572] An organic EL device was prepared under the same conditions as in Example 3, except that Compound 1-34 of Synthesis Example 6 was used instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 5

[0573] An organic EL device was prepared under the same conditions as in Example 1, except that Compound 3-14 of Synthesis Example 45 was used instead of Compound 2-4 of Synthesis Example 23, as the material for the luminous layer 6. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

##STR00074##

Example 6

[0574] An organic EL device was prepared under the same conditions as in Example 5, except that Compound 1-34 of Synthesis Example 6 was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 7

[0575] An organic EL device was prepared under the same conditions as in Example 5, except that the pyrimidine derivative 4-125 was used, instead of the pyrimidine derivative 4-123, as the material for the electron transport layer 7. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 8

[0576] An organic EL device was prepared under the same conditions as in Example 7, except that Compound 1-34 of Synthesis Example 6 was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 9

[0577] An organic EL device was prepared under the same conditions as in Example 1, except that a carbazole derivative 3-16 of the following structural formula was used, instead of Compound 2-4 of Synthesis Example 23, as the material for the luminous layer 6. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

##STR00075##

Example 10

[0578] An organic EL device was prepared under the same conditions as in Example 9, except that Compound 1-34 of Synthesis Example 6 was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 11

[0579] An organic EL device was prepared under the same conditions as in Example 9, except that the pyrimidine derivative 4-125 was used, instead of the pyrimidine derivative 4-123, as the material for the electron transport layer 7. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Example 12

[0580] An organic EL device was prepared under the same conditions as in Example 11, except that Compound 1-34 of Synthesis Example 6 was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Comparative Example 1

[0581] An organic EL device was prepared under the same conditions as in Example 3, except that a triarylamine compound 6′-2 represented by the following structural formula was used, instead of Compound 6-1, as the material for the first hole transport layer 5a, and the triarylamine compound 6′-2 represented by the following structural formula was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. In this case, the first hole transport layer 5a and the second hole transport layer 5b functioned as an integrated hole transport layer (film thickness 65 nm). As clear from the structural formula, Compound (6′-2) was a triarylamine compound having two triarylamine structures in the molecule. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

##STR00076##

Comparative Example 2

[0582] An organic EL device was prepared under the same conditions as in Example 7, except that the triarylamine compound 6′-2 represented by the above structural formula was used, instead of Compound 6-1, as the material for the first hole transport layer 5a, and the triarylamine compound 6′-2 represented by the above structural formula was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. In this case, the first hole transport layer 5a and the second hole transport layer 5b functioned as an integrated hole transport layer (film thickness 65 nm). The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

Comparative Example 3

[0583] An organic EL device was prepared under the same conditions as in Example 11, except that the triarylamine compound 6′-2 represented by the above structural formula was used, instead of Compound 6-1, as the material for the first hole transport layer 5a, and the triarylamine compound 6′-2 represented by the above structural formula was used, instead of Compound 1-5 of Synthesis Example 1, as the material for the second hole transport layer 5b. The resulting organic EL device was measured for the light emission characteristics when a direct current voltage was applied at normal temperature in the atmosphere. The layer configuration is shown in Table 1, and the results of the measurements are shown in Table 2.

[0584] In Table 2, the device life in each of the organic EL devices of the Examples and the Comparative Examples was measured as the period of time until the emission luminance attenuated to 6790 cd/m.sup.2 (corresponding to 97%, with the initial luminance taken as 100%: 97% attenuation) when constant current driving was performed, with the emission luminance at the start of light emission (initial luminance) being set at 7000 cd/m.sup.2.

TABLE-US-00009 TABLE 1 First hole Electron transport Second hole Luminous transport layer transport layer layer layer Ex. 1 Compound Compound 1-5 Compound 2-4/ Compound 6-1 EMD-1 4-123/ ETM-1 Ex. 2 Compound 1-34 Ex. 3 Compound 1-5 Compound Ex. 4 Compound 1-34 4-125/ ETM-1 Ex. 5 Compound 1-5 Compound Compound Ex. 6 Compound 1-34 3-14/EMD-1 4-123/ ETM-1 Ex. 7 Compound 1-5 Compound Ex. 8 Compound 1-34 4-125/ ETM-1 Ex. 9 Compound 1-5 Compound Compound Ex. 10 Compound 1-34 3-16/EMD-1 4-123/ ETM-1 Ex. 11 Compound 1-5 Compound Ex. 12 Compound 1-34 4-125/ ETM-1 Comp. Compound Compound 6′-2 Compound 2-4/ Compound Ex. 1 6′-2 EMD-1 4-125/ Comp. Compound ETM-1 Ex. 2 3-14/EMD-1 Comp. Compound Ex. 3 3-16/EMD-1

TABLE-US-00010 TABLE 2 Device Luminous Power life Voltage Luminance efficiency efficiency 97% (@10 mA/ (@10 mA/ (@10 mA/ (@10 mA/ attenu- cm.sup.2) cm.sup.2) cm.sup.2) cm.sup.2) ation [V] [cd/m.sup.2] [cd/A] [lm/W] (hrs) Ex. 1 4.26 2704 27.01 19.95 277 Ex. 2 4.20 2660 26.56 19.85 255 Ex. 3 4.17 2635 26.31 19.85 255 Ex. 4 4.09 2575 25.72 19.77 320 Ex. 5 3.51 2574 25.78 23.17 361 Ex. 6 3.40 2530 25.30 23.46 388 Ex. 7 3.39 2529 25.30 23.47 298 Ex. 8 3.30 2513 25.13 23.99 369 Ex. 9 3.87 2492 24.95 20.28 200 Ex. 10 3.80 2521 25.23 20.69 241 Ex. 11 3.82 2514 25.15 20.68 283 Ex. 12 3.75 2500 25.03 20.80 358 Comp. Ex. 1 4.12 2230 22.33 17.04 96 Comp. Ex. 2 3.42 1984 19.85 18.24 79 Comp. Ex. 3 3.83 2015 20.16 16.55 68

[0585] Examples 1 to 4 and Comparative Example 1, using the same combination of the materials for the luminous layer, were compared by reference to Tables 1 and 2. The luminous efficiency was 22.33 cd/A in Comparative Example 1, while it was as high as 25.72 to 27.01 cd/A in all of Examples 1 to 4. The power efficiency was 17.04 lm/W in Comparative Example 1, while it was as high as 19.77 to 19.95 lm/W in all of Examples 1 to 4. The device life was 96 hours in Comparative Example 1, but was 255 to 320 hours in Examples 1 to 4, showing much longer life.

[0586] Examples 5 to 8 and Comparative Example 2, using the same combination of the materials for the luminous layer, were compared by reference to Tables 1 and 2. The luminous efficiency was 19.85 cd/A in Comparative Example 2, while it was as high as 25.13 to 25.78 cd/A in all of Examples 5 to 8. The power efficiency was 18.24 lm/W in Comparative Example 2, while it was as high as 23.17 to 23.99 lm/W in all of Examples 5 to 8. The device life was 79 hours in Comparative Example 2, but was 298 to 388 hours in Examples 5 to 8, showing much longer life.

[0587] Examples 9 to 12 and Comparative Example 3, using the same combination of the materials for the luminous layer, were compared by reference to Tables 1 and 2. The luminous efficiency was 20.16 cd/A in Comparative Example 3, while it was as high as 24.95 to 25.23 cd/A in all of Examples 9 to 12. The power efficiency was 16.55 lm/W in Comparative Example 3, while it was as high as 20.28 to 20.80 lm/W in all of Examples 9 to 12. The device life was 68 hours in Comparative Example 3, but was 200 to 358 hours in Examples 9 to 12, showing much longer life.

[0588] With the organic EL device of the present invention, an arylamine compound having a specific structure and a heterocyclic compound having a specific condensed ring structure (and a specific pyrimidine derivative) are combined so as to improve the carrier balance within the organic EL device and to achieve a carrier balance suited to the characteristics of a luminous material. Hence, an organic EL device with a high luminous efficiency and a long life in comparison with conventional organic EL devices can be realized.

INDUSTRIAL APPLICABILITY

[0589] The organic EL device of the present invention using the arylamine compound having the specific structure and the heterocyclic compound having the specific condensed ring structure (and the specific pyrimidine derivative) in combination is increased in luminous efficiency, and improved in durability. Hence, the organic EL device of the present invention can be put to uses such as domestic electrical appliances and illumination.

DESCRIPTION OF REFERENCE NUMERALS

[0590] 1 Glass substrate [0591] 2 Transparent anode [0592] 3 Hole injection layer [0593] 5 Hole transport layer [0594] 5a First hole transport layer [0595] 5b Second hole transport layer [0596] 6 Luminous layer [0597] 7 Electron transport layer [0598] 8 Electron injection layer [0599] 9 Cathode.

ORGANIC ELECTROLUMINESCENT DEVICE

Assignee

Inventors

Cpc classification

Classification Explorer

C07C211/61

CHEMISTRY; METALLURGY

Classification Explorer

C09B57/008

CHEMISTRY; METALLURGY

Classification Explorer

H10K50/81

ELECTRICITY

Classification Explorer

H10K85/631

ELECTRICITY

Classification Explorer

C09K2211/1029

CHEMISTRY; METALLURGY

Classification Explorer

H10K50/11

ELECTRICITY

Classification Explorer

C07D495/04

CHEMISTRY; METALLURGY

Classification Explorer

H10K50/156

ELECTRICITY

Classification Explorer

C09K11/06

CHEMISTRY; METALLURGY

Classification Explorer

H10K2101/10

ELECTRICITY

Classification Explorer

C09K2211/185

CHEMISTRY; METALLURGY

Classification Explorer

H10K85/6572

ELECTRICITY

Classification Explorer

H10K50/82

ELECTRICITY

Classification Explorer

C07D495/14

CHEMISTRY; METALLURGY

Classification Explorer

H10K85/654

ELECTRICITY

Classification Explorer

C07D403/04

CHEMISTRY; METALLURGY

Classification Explorer

H10K85/633

ELECTRICITY

Classification Explorer

H10K85/657

ELECTRICITY

Classification Explorer

C07D491/048

CHEMISTRY; METALLURGY

Classification Explorer

H10K85/342

ELECTRICITY

Classification Explorer

H10K50/16

ELECTRICITY

Classification Explorer

C07C211/54

CHEMISTRY; METALLURGY

International classification

Classification Explorer

H01L51/00

ELECTRICITY

Classification Explorer

C07D403/04

CHEMISTRY; METALLURGY

Classification Explorer

C09K11/06

CHEMISTRY; METALLURGY